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Alcohol to be included in new 
substance misuse strategy
Dublin hosts 2009 European 
Health Libraries workshop 
John Curran TD, minister of state with 
responsibility for the drugs strategy, announced 
on 31 March 2009 that the Government 
had approved a combined substance misuse 
policy to include both alcohol and drugs. 
This proposal was brought to Government 
by the Department of Community, Rural and 
Gaeltacht Affairs and the Department of Health 
and Children. 
Making the announcement, Minister 
Curran said: 
A combined strategy will facilitate a more 
coherent approach to the issues and 
consequences of alcohol and illicit drug 
use including addictive behaviours. We 
cannot continue to look at these problems 
in isolation. 
Questioned about the new strategy in Dáil 
Éireann on 29 April 2009, the Minister said: 
I expect to be presenting the draft 
strategy to Government for consideration 
in late May or early June. The measure, 
as approved by Government, will be 
published as an interim strategy pending 
the drafting and fi nalisation of a national 
substance misuse strategy. In this context, 
the Deputies should note that a new 
steering group will be established in the 
autumn to develop proposals for the 
overall substance misuse strategy, which 
will incorporate the already agreed drugs 
policy element. The group will be asked to 
report by the end of 2010.1
1. Curran J (2009, 29 April) Parliamentary 
Debates Dáil Éireann (Offi cial Report – 
Unrevised), Vol. 681, No. 2: 362.
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Attending the launch of the EAHIL 2009 Workshop in Dublin Castle were (l to r): Enda 
Connolly, CEO Health Research Board; Louise Farragher (National Documentation Centre 
on Drug Use), Chair of the organising committee; Mary Harney TD, Minister for Health and 
Children; Suzanne Bakker, President of EAHIL; and Paul Murphy, Chair of the programme 
committee. (Photo: Richard Stokes)
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The European Association for Health Information 
and Libraries 2009 biennial workshop was held 
in Dublin Castle on 2–5 June. The workshop 
was hosted by the Health Science Libraries 
Group of the Library Association of Ireland and 
by the Health Research Board. Louise Farragher 
of the National Documentation Centre on Drug 
Use chaired the committee which organised 
the event, the largest of its kind to be held in 
Ireland. 
Opened by Mary Harney TD, Minister for Health 
and Children, the workshop was attended by 
over 230 delegates from Europe, North America 
and South Africa. The programme comprised 
seven continuing education courses, eight 
empowerment workshops, six plenary papers, 
30 posters and 38 paper presentations, all based 
on the theme ‘Working with Others.’ 
In her opening address Ms Harney 
acknowledged the important role of information 
professionals in the conversion of information 
into the knowledge which is needed to 
inform decision making in the health system. 
Information scientists and librarians must 
present evidence in a clear and understandable 
way and deliver it to the right people at the 
right time, through guidelines, protocols and 
other information supports. Minister Harney 
emphasised the importance of ensuring that 
evidence-based decision making is understood 
at all levels, including the political level. 
Information professionals have a role to play 
in informing public opinion and winning 
support for change. Unlike lobbyists and 
interest groups, their interest is in providing 
the most relevant information and they should 
be prepared to knock on the doors of health 
ministries and other policy makers to ensure 
that this is information is available where it is 
needed. Paul Murphy, chair of the workshop’s 
programme committee, thanked the staff of the 
18 Irish healthcare and educational institutions 
who were involved in the organisation of the 
workshop.
EAHIL Workshop 2009 (continued)
International conference on 
drug policy 
The third annual conference of the International 
Society for the Study of Drug Policy (ISSDP) was 
held in Vienna between 2 and 4 March 2009. 
Scholars, analysts and researchers from around 
the world met to hear some 50 papers on the 
following themes:
Cannabis, including production, markets • 
and policy
Politics, values and science in drug • 
policy formation
Policy analytic frameworks including • 
harm reduction
Policy assessment including cross-• 
national comparisons
Public expenditure on the drugs issue • 
and the cost of drug use
Statistical modelling and microsimulation• 
On the third day there were two half-day 
workshops on compiling a drug-harm index and 
on modelling. 
The variety of the conference programme 
is illustrated by the following quotations 
taken from the presentations of a selection of 
contributors:
Law enforcement agencies can make • 
a substantial contribution to reducing 
drug-related harms, for example by 
seeking to eliminate ‘noxious’ dealing, 
which is defi ned as including additional 
elements such as violence, corruption, 
terror or environmental damage. While 
such action may not reduce the size 
of the drug market, it will reduce the 
amount of collateral damage. Similarly, 
ensuring that children and other 
dependants of those arrested for drug-
related offences are not exposed to 
dangers or risks as a consequence of the 
arrest will also help to contain the extent 
of the harm infl icted. 
(Jonathan Caulkins, USA)
There are at least two important and • 
ignored topics in the literature on 
the social cost of illegal drugs. First, 
social cost ignores human suffering 
associated with drugs. Second, it does 
not focus on friends and family of the 
drug user. These failures result in an 
under-estimation of the overall size of 
the cost of drug use and, in turn, lead 
to an under-prioritisation of the issue of 
human suffering. 
(Hans Olav Melburg, Norway)
If states do decide to make cannabis • 
legally available, it is recommended that 
a system of strict government-controlled 
regulation be employed, with controls 
on price, quality, potency and availability 
along with good public education about 
drugnet 
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3International context for Ireland’s new 
drugs strategy
Since 2001 Ireland’s drugs strategy has been formulated 
within the context of the policy frameworks on illicit drugs 
adopted by the UN and the EU. While broadly similar in 
approach, there are differences in emphasis between the UN 
and EU frameworks which leave room for member states, 
such as Ireland, to exercise some discretion in developing 
national policy priorities. Some features of the current 
international illicit drug policy frameworks of relevance to 
Ireland’s drugs strategy are noted here.1
In their illicit drugs strategies both the UN and the EU 
reaffi rm the primacy of the three international drug control 
conventions as the basis for drug policy, acknowledge the 
rule of law and undertake to uphold respect for concepts 
such as human dignity, liberty, democracy, equality, 
solidarity, and human rights. In setting out their high-level 
aspirations with regard to illicit drugs, however, the two 
entities diverge. 
The UN’s ultimate goal is ‘to minimize and eventually  ■
eliminate the availability and use of illicit drugs and 
psychotropic substances in order to ensure the health 
and welfare of humankind’, to which end it encourages 
‘the exchange of best practices in demand and supply 
reduction’, and emphasises that ‘each strategy is 
ineffective in the absence of the other’. 
The EU has two aims: to contribute to ‘the attainment of  ■
a high level of health protection, well-being and social 
cohesion by complementing the Member States’ action 
in preventing and reducing drug use, dependence and 
drug-related harms to health and society’ and to ensure 
‘a high level of security for the general public by taking 
action against drugs production, cross-border traffi cking 
in drugs and diversion of precursors, and by intensifying 
preventive action against drug-related crime, through 
effective cooperation embedded in a joint approach’. 
In other words, unlike the UN, the EU stops just short of 
seeking a drug-free world.
Both international frameworks emphasise the need for 
an integrated, multidisciplinary, mutually reinforcing and 
balanced approach to supply and demand reduction 
strategies. At this point, however, the two bodies diverge: 
the EU uses the term ‘harm reduction’ but the UN prefers a 
vaguer term, ‘related support services’. To elaborate:
The EU calls for the development and improvement of  ■
‘an effective and integrated comprehensive knowledge-
based demand reduction system including prevention, 
early intervention, treatment, harm reduction, 
rehabilitation and social reintegration measures within 
the EU member states’. It further states that drug 
demand reduction measures must take into account 
the health-related and social problems caused by the 
use of illegal psychoactive substances and of polydrug 
use in association with legal psychoactive substances 
such as tobacco, alcohol and medicines. Furthermore, it 
calls for the different levels of health risks involved with 
different forms of drug use (such as polydrug use) or life 
periods and specifi c situations (such as early adolescence, 
pregnancy, driving under the infl uence of drugs) to be 
taken into account in developing demand reduction 
interventions.
The UN affi rms its commitment to ‘effective,  ■
comprehensive, integrated drug demand reduction 
programmes, based on scientifi c evidence and covering 
a range of measures, including primary prevention, 
early intervention, treatment, care, rehabilitation, social 
reintegration and related support services’. It states 
that demand reduction strategies should be aimed 
at promoting health and social well-being among 
individuals, families and communities and reducing the 
the harms of cannabis use and bans or restrictions 
on advertising and promotion. The effects of any 
changes need to be closely monitored and inform 
prompt revision of the changes if indicated. 
(Peter Reuter, USA)
A study of how Australian policy-makers obtain • 
advice on policy development shows that research 
evidence is but one bit-player in the overall decision-
making process. This fi nding suggests that ‘evidence-
informed’ policy may be a more accurate description 
of the way that research fi ndings infl uence policy 
than the more usual term ‘evidence-based’ policy. 
(Alison Ritter, Australia)
Benefi ts are to be gained from combining research • 
into illicit drugs, alcohol and tobacco. 
(Robin Room, Australia)
The drugs problem is a complex constellation of • 
issues and diffi culties associated with the production, 
distribution and consumption of illegal drugs. 
Viewing it as a governance problem may open 
up more effective ways of tackling the various 
dimensions, drawing on a number of different social 
science perspectives on governance to develop new 
and integrated approaches. 
(Toby Seddon, UK) 
Diversifi ed oral substitution is not able to eradicate • 
risk behaviours or to attract those morphine users 
who are not able or not willing to stop injecting. 
For those users, programmes offering injectable 
preparations of substances for substitution seem to 
constitute the more adequate option. 
(Alfred Springer, Austria)
Further information on the conference, and on the two 
preceding annual conferences, is available on the website of 
the ISSDP www.issdp.org. 
(Brigid Pike)
International conference on drug policy (continued)
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Is the ‘ﬁ ght against drug abuse’ at EU 
level adding value? 
Within the EU, Irish citizens are among those most 
concerned about the drugs issue and most supportive of 
EU-level action in relation to drugs. However, Irish citizens 
are also among those who do not see the added value 
of the actions being taken at EU-level compared to those 
being taken at national level. They are also among those not 
entirely satisfi ed with the EU’s communications regarding its 
fi ght against drugs. 
These fi ndings were reported in a Flash Eurobarometer 
report on a survey of awareness among EU citizens of key 
policies in the Freedom, Security and Justice area, 
published in January 2009.1 The aim of the survey was 
to examine the level of concern that EU citizens feel 
about policies in the Freedom, Security and Justice area, 
the amount of support for EU-level actions in that area, 
and citizens’ opinions as to whether the EU should be 
communicating its policies more effi ciently. 
Level of concern 
The survey results showed that a majority of respondents feel 
concerned about each of the nine policy areas covered in the 
survey. Primarily, the interviewees are concerned about the 
fi ght against organised crime and terrorism and against drug 
abuse (both 80%). Concern about the fi ght against drug 
abuse is highest in southern European countries – Cyprus, 
Portugal, Malta, Greece and Spain (between 91% and 95%). 
In Ireland nine out of 10 citizens say they are concerned 
about the drugs issue. 
Support for EU-level action
EU citizens largely feel that EU-level actions add the most 
value in the fi ght against organised crime and terrorism 
(72%), and then in the fi ght against drug abuse and the 
promotion and protection of fundamental rights, including 
children’s rights (both 65%). Contrary to this overall pattern, 
citizens of Luxembourg and Portugal believe that the fi ght 
against drug abuse benefi ts more than the fi ght against 
organised crime and terrorism from actions taken at EU-
level compared to those at national level (both 76%; 11 
percentage points above the EU average). They are followed 
by citizens from Spain (74%), Sweden and Belgium (73%), 
and Ireland (72%). 
Citizens’ level of concern and support for EU-level action 
Ireland is among the top fi ve countries whose citizens 
combine concern about the issue and support EU-level 
action in the fi ght against organised crime and terrorism 
(71%), in the fi ght against drug abuse (67%), and in the 
protection of fundamental rights (71%). At the same time, 
19% of Irish citizens say they are concerned about the fi ght 
against drug abuse but do not see value being added by 
actions being taken at EU-level compared to the national 
level alone. 
Views on effi ciency of communication of policies to 
EU citizens
Overall, three-quarters of respondents think the EU should 
improve its dissemination of information on its policies and 
adverse consequences of drug abuse for individuals and 
society as a whole, taking into account the particular 
challenges posed by high-risk drug users, in full 
compliance with the three international drug control 
conventions and in accordance with national legislation. 
It also states that member states should ensure access to 
demand reduction interventions on a non-discriminatory 
basis, in detention facilities as elsewhere, bearing in 
mind that those interventions should also consider 
vulnerabilities that undermine human development, such 
as poverty and social marginalisation. 
Both international bodies acknowledge the need for 
evidence-based policy. The UN calls for member states 
to develop and use ‘indicators and instruments for the 
collection and analysis of accurate, reliable and comparable 
data’. The EU’s overall objective in relation to information, 
research and evaluation suggests that the EU drug research 
community is at a more advanced stage of development 
than the UN equivalent: the EU strategy calls for ‘a better 
understanding of the drugs problem and the development 
of an optimal response to it through a measurable and 
sustainable improvement in the knowledge base and 
knowledge infrastructure’. 
Drugs policy researcher Professor Peter Reuter argues that 
over the past 10 years policy makers around the world 
have tended to ignore the growing body of evidence 
showing that drug use prevalence has been insensitive to 
policy interventions.2 According to Reuter, no prevention, 
treatment or enforcement strategies have demonstrated 
an ability to substantially affect the extent of drug use and 
addiction. He calls on the drugs policy community to be 
open to reviewing all the evidence and exploring new policy 
options: ‘… discussion of policy should pay more attention 
to how few of the intended effects are achieved by most 
policies and how many and troubling are the unintended 
effects, particularly of tough enforcement’ (p. 515). 
(Brigid Pike)
1. This account is based on a reading of two documents: 
the EU Drugs Strategy 2005–2012 (CORDROGUE 
77), retrieved on 24 March 2009 from www.emcdda.
europa.eu and the UN Draft Political Declaration (E/
CN.7/2009/L.2), retrieved on 24 March 2009 from www.
unodc.org . The latter document, together with a 10-
year action plan, was agreed at the High-Level Segment 
of the 52nd Session of the Commission on Narcotic 
Drugs (CND), which met in Vienna in March 2009. 
2. Reuter P (2009) Ten years after the United Nations 
General Assembly Special Session (UNGASS): assessing 
drug problems, policies and reform proposals. Addiction, 
(104): 510–517.
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terrorism (78%), the fi ght against drug abuse (76%) and the 
promotion and protection of fundamental rights, including 
children’s rights (75%). The highest proportions of citizens 
not completely satisfi ed with the EU’s communication in 
the area of the fi ght against drug abuse are to be found in 
Greece, Ireland and Portugal, with 88%, 86% and 
85% of respondents, respectively, seeing the need for 
better communication. 
(Brigid Pike)
1. Gallup Organization (2009) Flash Eurobarometer 252: 
Awareness of key-policies in the area of Freedom, Security 
and Justice. Brussels: European Commission. Retrieved on 
9 April 2009 at www.ec.europa.eu/public_opinion. The 
fi eldwork was carried out between 5 and 9 September 
2008. Over 27,000 randomly selected citizens aged 15 
years and over were interviewed in the 27 EU member 
states. Approximately 1,000 interviews were carried out 
in each country, predominantly via fi xed telephone lines 
using WebCATI (web-based computer assisted telephone 
interviewing). To correct for sampling disparities, a post-
stratifi cation weighting of the results was implemented, 
based on important socio-demographic variables. Details 
on the survey methodology are included in the Annex of 
the report. The policies surveyed included immigration 
policy, asylum policy, the exchange of police and 
judicial information between member states, the fi ght 
against organised crime and terrorism, the fi ght against 
drugs abuse, the control of the EU’s external borders, 
the promotion and protection of fundamental rights, 
including children’s rights, and the improvement of 
access to justice. 
Flash Eurobarometer (continued)
In 2007/08 local drugs task forces (LDTFs) completed a 
strategic review and planning process, undertaken at the 
invitation of the National Drugs Strategy Team (NDST). The 
object of the exercise was to identify the needs in LDTF areas 
in relation to drug misuse, to contribute to the ‘renewal’ 
of LDTFs by enabling the sharing among all agencies and 
sectors of a clear strategic focus, and to help inform the 
choice of future drug strategies. This article summarises the 
fi ndings of an unpublished analysis of the reports furnished 
to the NDST by the 13 LDTFs.1
Community profi les
The LDTFs identifi ed a number of common themes 
indicating continuing social deprivation in their areas, 
including lower levels of educational attainment and higher 
levels of unemployment, local authority housing and lone 
parent households than the national average. They also 
outlined how local settlement patterns may be affecting their 
work. LDTF catchment areas may contain neighbourhoods 
experiencing deprivation interspersed with neighbourhoods 
experiencing ‘signifi cant advantage’: this presents challenges 
for targeting services effectively. Certain LDTFs have seen 
the ‘gentrifi cation’ of their areas: this has led to heightened 
feelings of isolation and marginalisation among some of the 
original residents.
Nature and extent of drug use
The LDTFs reported that heroin is still the primary drug of 
misuse. However, there has been a signifi cant increase in 
the use of cocaine, alcohol and prescription drugs. In line 
with this expansion, the incidence of polydrug use has 
also increased. With regard to users, the LDTFs highlighted 
the much higher drug-use prevalence among males than 
females. They drew attention to the increased drug use 
among non-Irish and Traveller communities, and among 
the homeless. They also noted the increased prevalence of 
blood-borne viral infections and the relationship between 
drug misuse and mental health. These patterns of drug 
use raise challenging issues with regard to the design and 
delivery of effective drug-related services. 
Gaps in services 
A range of gaps in service provision was highlighted by the 
LDTFs, including: 
services that are accessible to non-national communities, ■
childcare services for clients wanting to attend treatment  ■
and rehabilitation services, 
drug services catering exclusively for the needs of young  ■
drug users, 
prevention initiatives for people in the early stages of  ■
drug use, 
services for people misusing alcohol, and ■
supply reduction initiatives at local level.  ■
Strategic priorities
The role of the LDTFs is to prepare action plans that will 
ensure the implementation of the national drugs strategy at 
local level. The LDTFs identifi ed strategic priorities under the 
pillars of the strategy, including the following:
Research: develop a comprehensive monitoring and  ■
evaluation system to measure the effectiveness of 
drug projects, and encourage projects piloting new 
programmes to evaluate them on a regular basis, and 
conduct locally based research projects.
Prevention: refocus prevention work to take into  ■
account peer processes, family support and community 
development, e.g. increase early intervention 
programmes in pre-school and early primary school 
years, with a special focus on children of drug users and 
children of families in diffi cult circumstances.
Treatment and rehabilitation: adopt the continuum  ■
of care approach to meeting the needs of clients, 
and develop an appropriate range of treatment and 
rehabilitation services for young people (aged 12–18 
years), e.g. develop a separate strategy for under-18s, 
LDTFs look to 2009 and beyond 
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On 31 March 2009, Minister for Health and Children, Mary 
Harney TD, announced that 1-benzylpiperazine (BZP) is 
now a controlled drug under statutory instruments (121 
and 122 of 2009) amending the Misuse of Drugs Act 1977, 
and that its possession or sale is now a criminal offence. The 
new statutory instruments will ensure that BZP is no longer 
available for sale in ‘head shops’ around the country or on 
the streets. 
BZP is a relatively new synthetic psychotropic (mood 
altering) substance which has been sold as ecstasy under the 
street names ‘Legal E’, ‘Legal X’ ‘XTC’, ‘A2’, ‘piperazine’, or 
‘party pills’. In Ireland, party pills containing BZP have been 
widely sold in head shops. 
The European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) conducted a risk assessment of BZP 
in 2007 and found that its use can lead to various medical 
problems, though the long-term effects of the substance 
are still unknown. The risk assessment report concluded 
that due to its stimulant properties, risk to health and the 
lack of medical benefi ts there was a need to control BZP. 
Against this background, the Council of the European Union 
decided in July 2007 that BZP should be defi ned as a new 
psychoactive substance which was to be made subject to 
control measures and criminal provisions.1 
(Jean Long)
1. See long J (2007) BZP - information exchange, risk 
assessment and control measures. Drugnet Ireland, 
(23): 21. 
or pilot psychosocial support projects for under-18s in 
collaboration with the HSE.
Supply reduction: support existing anonymous ‘dial to  ■
stop drug dealing’ type initiatives and establish similar 
schemes in LDTF areas where they currently do not exist; 
hold community information evenings to exchange 
information, network and build and develop 
partnerships between the gardaí, the community and 
drug-related services.
Family support and co-ordination: establish training in  ■
strengthening families for all workers, and put in place 
early intervention initiatives to build capacity within 
families; develop policies and procedures to improve 
communication across the various groups and projects 
active within the LDTF areas.
Effectiveness of LDTF structures
LDTFs were generally positive about their role in introducing 
and supporting drug-related services and initiatives and 
were also confi dent that their structures and processes were 
functioning effectively. The management of mainstreamed 
projects, and the ongoing role and responsibility of LDTFs 
with regard to these projects, was raised as an issue. In 
parallel, some LDTFs highlighted the limited input and in 
some cases lack of interest on the part of statutory services 
regarding the task force process, and lack of clarity about 
their own roles on the LDTFs. Strategic priorities included: 
increasing the profi le and understanding of the work of  ■
the LDTFs in the community through the development 
of comprehensive communication strategies, 
facilitating the involvement of people affected by drug  ■
addiction in the work of the task forces by supporting 
the establishment of service-user forums, and
developing key performance indicators and systems  ■
to monitor progress and inform future development 
across programmes. 
(Brigid Pike) 
1. Foran S (2008) Local drug task force strategic review 
and planning process 2008–2013: An overview. Report 
prepared for the NDST. Not published. 
LDTFs look to 2009 and beyond (continued)
Directory of community drugs projects 
CityWide Drugs Crisis Campaign has compiled a directory 
of community-based drugs projects in Dublin and Wicklow.1 
The purpose of the directory is to facilitate the development 
of formal links between prison and community services by 
providing up-to-date information on community projects, 
their services, locations and contact details. 
The directory is an initiative of a Dublin Prison Liaison Group 
which includes members of the Irish Prison Service, prison 
staff and representatives from community-based projects. 
The Liaison Group has been operating since 2000 in an 
effort to improve throughcare between prison services and 
community services for drug users.
The directory can be accessed on the CityWide website at 
www.citywide.ie
(Anne Marie Donovan)
1. CityWide (2009) Directory of community drugs projects: 
working with individuals within Irish prisons and post 
release services. Dublin: CityWide. 
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Force strategic plan 
The Minister of State with responsibility for drugs strategy, 
John Curran TD, launched the Dublin 12 Local Drugs 
Task Force strategic plan 2009–2013 on 12 May 2009 at 
the Red Cow Moran Hotel. The launch was followed by 
workshops on a number of themes, including the availability 
of treatment, rehabilitation, education and prevention 
initiatives, and families dealing with drug issues. The plan 
is the product of extensive consultation with stakeholders 
in the catchment areas of Crumlin, Drimnagh, Kimmage 
and Walkinstown. Specifi c aims and objectives in the new 
strategy include:
Treatment – continue to develop the Cross Task Force 
harm reduction/needle exchange service and increase 
collaboration between drug treatment and alcohol services. 
Rehabilitation – lobby for a rehabilitation/integration service 
(RIS) and increased rehabilitation options, and develop 
forums and networks such as the D12 Service Users Forum.
Education – consolidate and develop interventions aimed at 
young people at risk, develop links with schools and provide 
accredited addiction studies courses locally.
Supply control – work towards implementing initiatives 
such as the Joint Policing Committees and the Dial to Stop 
Drug Dealing campaign, and develop the Community 
Safety Partnership with the gardaí and other community 
stakeholders.
Research – strengthen data, collection systems, commission 
local research to inform service planning, and participate in 
national-level studies.
Family support – re-establish family support groups and 
support the development of child care facilities for drug-
using families.
Alcohol – develop a plan to address alcohol misuse, 
identify local alcohol services and form stronger relationships 
with them. 
(Anne Marie Donovan)
1. Dublin 12 Local Drugs Task Force (2009) Strengthening 
our collective responses: strategic plan 2009–2013. Dublin: 
Dublin 12 LDTF. Available online from the National 
Documentation Centre library at www.hrb.ie/ndc 
Sedative, tranquilliser and 
anti-depressant use in Ireland 
The sixth bulletin of results from the 2006/7 all-Ireland 
general population drug prevalence survey focuses on 
sedative or tranquilliser and anti-depressant use in the adult 
population (15–64 years).1 The fi nal achieved sample was 
4,967 in Ireland. This represented a response rate of 65%. 
This article highlights some of the survey fi ndings and 
presents unpublished data from the National Drug 
Treatment Reporting System (NDTRS) and the National 
Drug-Related Deaths Index (NDRDI).
Use by adult population in 2006/7
The proportion of adults who reported using a sedative or 
tranquilliser2 at some point in their lives was almost 11% 
(Table 1a). The proportion of young adults was 6%, while 
the proportion of older adults was higher at just under 
15%. More women (13%) than men (8%) reported using a 
sedative or tranquilliser in their lifetime. 
The proportion of adults who reported using a sedative or 
tranquilliser in the last year was almost 5%, and of older 
adults almost 7% (Table 1a). 
The proportion of adults who reported using a sedative or 
tranquilliser in the last month was 3%, and of older adults 
just over 4% (Table 1a). 
Table 1a Prevalence of sedative and tranquilliser use in Ireland, 2006/7
Adults 
15–64 years 
(%)
Males 
15–64 years 
(%)
Females 
15–64 years
(%)
Young adults 
15–34 years
(%)
Older adults 
35–64 years
(%)
Lifetime (ever used) 10.5 8.0 13.2 5.9 14.6
Last year (recent use) 4.7 3.7 5.7 2.5 6.5
Last month (current use) 3.0 2.4 3.5 1.3 4.4
Source: NACD and DAIRU (Bulletin 6, 2009) 
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Minister John Curran at the launch of the strategic plan 
(Photo: Tara O’Reilly) 
8The proportion of adults who reported using an anti-
depressant3 at some point in their lives was just over 9% 
(Table 1b). The proportion of young adults was 7% while 
the proportion of older adults was higher at just under 
11%. More women (13%) than men (6%) reported using an 
anti-depressant in their lifetime. 
The proportion of adults who reported using an anti-
depressant in the last year was just over 4%, and of older 
adults just over 5% (Table 1b). 
The proportion of adults who reported using an anti-
depressant in the last month was just over 3%, and of older 
adults just under 4% (Table 1b).
Practices among users – 2006/7 survey 
Those who had ever used: The average age at fi rst use of 
sedatives or tranquillisers was 29 years for males and 31 for 
females. The average age at fi rst use of anti-depressants was 
34 years for males and 30 years for females. 
Current users: More than half (57%) of current users of 
sedatives or tranquillisers, and 91% of current users of 
anti-depressants, took them daily or almost daily. Most 
current users got their sedatives or tranquillisers (89%) or 
anti-depressants (100%) on prescription. However, 11% of 
sedative or tranquilliser users reported that they had either 
got them from a friend or another source or bought them 
without a prescription in a pharmacy. 
Sedative or tranquilliser and anti-depressant use was more 
likely among those who were dependent on the state long-
term, were not in paid employment, had lower levels of 
educational attainment and had left education before the 
age of 15 years. 
Respondents who were separated, divorced or widowed 
reported higher prevalence rates of sedative or tranquilliser 
and anti-depressant use compared to those who were single 
(never married), co-habiting or married. 
Use by 15–16-year-old school children – 
2007 ESPAD survey
One in ten of the 2007 ESPAD survey participants reported 
that they had taken prescribed sedatives or tranquillisers at 
some point in their young lives, and 3% had taken non-
prescribed sedatives or tranquillisers.4
NDTRS data – sedatives or tranquillisers
According to NDTRS data for the years 2001 to 2007, 
the annual number of treated cases reporting sedatives or 
tranquillisers as a main problem drug ranged between 78 
and 171 (Table 2). The total for the period was 778 cases, 
of whom 87% reported a benzodiazepine as their main 
problem drug. Of the 778 cases, 76% used one or more 
additional drugs. 
Of the 171 cases treated in 2007 who reported sedatives 
or tranquillisers as their main problem drug, 98% ate them 
and 0.5% injected them. Use by these cases in the month 
prior to treatment was reported as follows: 66% used them 
daily, 12% used them between two and six days per week, 
5% used them once per week or less and 11% had not used 
them. Half had commenced use before they were 19 years 
old; 66% were men; and 61% lived in Dublin. 
Table 1b Prevalence of anti-depressant use in Ireland, 2006/7
Adults 
15–64 years 
(%)
Males 
15–64 years 
(%)
Females 
15–64 years
(%)
Young adults 
15–34 years
(%)
Older adults 
35–64 years
(%)
Lifetime (ever used) 9.2 5.9 12.5 7.1 10.9
Last year (recent use) 4.3 3.0 5.6 3.2 5.2
Last month (current use) 3.1 2.3 3.9 2.2 3.9
Source: NACD and DAIRU (Bulletin 6, 2009) 
Table 2 Cases entering treatment for sedatives or tranquillisers as a main problem drug, 2001 to 2007 
2001 2002 2003 2004 2005 2006 2007
Number (%)
All cases 4797 4948 5054 4506 4877 5191 5684
Cases reporting 
sedatives or tranquillisers 
as main problem drug 115 (2.4) 104 (2.1) 97 (1.9) 108 (2.4) 78 (1.6) 105 (2.0) 171 (3.0)
Of whom:
New cases 55 39 37 50 44 55 91
Previously treated cases 52 60 60 52 31 44 74
Treatment status not known 8 5 0 6 3 6 6
Source: Unpublished data from the NDTRS
Sedative and anti-depressant use in Ireland (continued)
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Table 3 Cases entering treatment who reported sedatives or tranquillisers as an additional problem drug, 
 2001 to 2007 
2001 2002 2003 2004 2005 2006 2007
Number (%)
All cases reporting an 
additional problem drug 3459 3582 3760 3157 3401 3692 3816
Cases reporting sedatives 
or tranquillisers as an 
additional problem drug 1107 (32.0) 1155 (32.2) 1050 (28.3) 1009 (32.0) 1110 (32.6) 1200 (32.5) 1155 (30.3)
Of whom:
New cases 252 264 214 176 206 269 273
Previously treated cases 786 826 791 685 747 771 681
Treatment status not known 32 43 26 31 26 21 14
Source: Unpublished data from the NDTRS
The number of cases reporting sedatives or tranquillisers 
as an additional problem drug exceeded 1,000 per year 
between 2001 and 2007 (Table 3). The main drugs 
associated with sedative or tranquilliser use by new cases 
entering treatment were cannabis, alcohol, stimulants, 
cocaine and opiates (Table 4). 
NDTRS data – anti-depressants
According to NDTRS data for the years 2001 to 2007, 
only 10 treated cases reported anti-depressants as a main 
problem drug, of whom half used one or more additional 
drugs. In the seven-year period, 56 cases reported anti-
depressants as an additional problem drug. The drugs 
associated with anti-depressant use were opiates and 
sedatives. Of the 66 cases treated who reported anti-
depressants as a problem drug, 53% were men, and 58% 
lived in Dublin. 
Table 4 Main problem drug and associated additional drugs used by new cases entering treatment, 2001–2007 
New cases 5741 1526 981 371 14 184 5693
Main problem drug
Opiates Cocaine Stimulants Sedatives/ 
tranquillisers
Hallucinogens Volatile 
inhalants
Cannabis
Additional problem 
drug(s) used*
 
Number 
Opiates 848† 102 26 52 2 4 151
Cocaine 1278 14† 272 59 3 3 1056
Stimulants 606 669 257† 62 9 14 2655
Sedatives/ 
tranquillisers 1267 110 39 27† 0 2 251
Hallucinogens 47 25 37 1 1† 1 165
Volatile inhalants 19 7 16 5 0 9† 127
Alcohol 2209 847 605 109 9 53 10
Cannabis 652 706 422 171 4 62 2719†
* By cases reporting use of one, two or three additional drugs. 
† Additional problem drug(s) used may be a form of drug in the same family as the main problem drug.
Source: Unpublished data from the NDTRS
NDRDI data
The NDRDI reported that there were 1,553 deaths as a 
result of poisoning between 1998 and 2005. The coroners 
reported that in 703 (45%) of these deaths sedatives, 
tranquillisers, and/or anti-depressants were implicated 
(either alone or in conjunction with other substances) 
(Table 5). Of those who died, 61% were male, 63% were 
aged between 20 and 44 years, and 44% were unemployed. 
Benzodiazepines were the most common form of sedative 
or tranquilliser implicated in these deaths. Only 113 
(16.1%) of the 703 poisoning deaths were attributable to 
drugnet 
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Use of minor tranquillisers and 
sedatives in the WRDTF area 
The fi rst in a series of three reports commissioned by the 
Western Region Drugs Task Force (WRDTF), this study1 
analysed treatment and prescription data relating to the use 
of minor tranquillisers and sedatives2 in the west of Ireland, 
and interviewed addiction service providers and a number of 
people recovering from addiction to these drugs. 
The early section of the report provides the legislative and 
regulative background to current prescribing practices. 
Department of Health and Children guidelines3 defi ne 
correct usage and good prescribing practice. A short 
literature review looks at the evidence of incorrect use of 
tranquillisers and sedatives internationally and the harmful 
consequences of this, including higher levels of 
risk-taking, fatal overdoses, and poorer health and 
psychological functioning.
Treatment and prescribing data
The study analysed data from the Health Research Board 
(HRB) National Drug Treatment Reporting System (NDTRS). 
These showed that of the 973 cases who entered treatment 
between 2001 and 2006, 114 (11.7%) reported problem 
benzodiazepine use. Only nine cases (less than 1%) reported 
benzodiazepines as a main problem drug. The vast majority 
of cases entering treatment for benzodiazepine use reported 
at least one other problem drug. The report points out 
that those presenting to a GP with an addiction to minor 
tranquillisers or sedatives are more likely to be referred for 
treatment to the HSE Mental Health Services than to the 
HSE Addiction Services. As the HSE Mental Health Services 
have only recently begun submitting treatment data to the 
NDTRS, there are probably a number of cases being treated 
who are not included in the treatment data analysed in 
this report.4 
Table 5 Number of poisoning deaths in which sedatives or tranquillisers, and/or anti-depressants were implicated, 
 NDRDI 1998–2005 
1998 1999 2000 2001 2002 2003 2004 2005
All poisoning deaths 178 187 182 175 210 184 205 232
Sedatives or tranquillisers* 88 77 79 57 79 72 87 78
Anti-depressants* 32 34 41 39 47 44 51 49
* Cases involving both sedatives or tranquillisers and anti-depressants are included in the fi gures for each type of substance. 
Source: Unpublished data from the NDRDI
Conclusions
The use of sedatives or tranquillisers by teenagers and adults 
is common in Ireland, and such use leads to dependence 
and fatalities. Benzodiazepines are the main type of sedative 
or tranquilliser used. In order to reduce the negative 
consequences of benzodiazepine misuse, the Department of 
Health and Children recommendations need to be revisited.5 
These included: improvement of the legislation, tighter 
monitoring and control of prescribing, improved clinical 
guidelines with an emphasis on short-term treatment and 
the use of alternative therapies. 
(Jean Long and Suzi Lyons)
1. National Advisory Committee on Drugs and Drug and 
Alcohol Information and Research Unit (2009) Drug 
use in Ireland and Northern Ireland. 2006/2007 drug 
prevalence survey: sedatives or tranquillisers, and anti-
depressants use results. Bulletin 6. Dublin: National 
Advisory Committee on Drugs.
2. ‘Sedatives’ and ‘tranquillisers’ are commonly used terms 
for the same group of medicines which depress, slow 
down or calm the brain and central nervous system. 
They are mainly benzodiazepines, but other drugs with 
the same effects, such as Zolpidem and Zopiclone, are 
included in this group. Medically they are often referred 
to as hypnotics, which induce sleep, and anxiolytics, 
which reduce anxiety. The same drug can be used as a 
hypnotic or as an anti-anxiety agent depending on the 
dose used and on the time of day that they are taken. 
3. Anti-depressants are medicines used to treat conditions 
such as the low or sad mood, loss of interest or pleasure 
in daily activities, fatigue and energy loss usually known 
as depression. Different drug classes are available on 
prescription to treat depression. 
4. Hibell B et al. (2009) The 2007 ESPAD report: substance 
use among students in 35 European countries. Stockholm: 
The Swedish Council for Information on Alcohol and 
Other Drugs (CAN) and the Pompidou Group of the 
Council of Europe.
5. The Benzodiazepine Committee (2002) Report of the 
Benzodiazepine Committee. Dublin: Department of Health 
and Children. 
a sedative, tranquilliser or antidepressant alone. Of the 590 
polysubstance deaths, over half (57.6%) also involved an 
opiate (often heroin or methadone) and 206 (34.9%) also 
involved alcohol. The number of deaths in which anti-
depressants played a part increased during the reporting 
period. 
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The study also looked at prescription records held by 
the HSE Primary Care Reimbursement Service (PCRS). 
Analysis of these data showed that 89,721 individuals were 
prescribed minor tranquillisers and sedatives between 
2000 and 2007. Almost 88% of prescriptions dealt with by 
the reimbursement service were for medical card holders. 
The number of people being prescribed these drugs rose 
from just below 25,000 to just over 33,000 during this 
period. These data would suggest that the 2002 prescribing 
guidelines have had little impact on prescribing practice in 
this region. 
Focus group and health personnel interviews
The author arranged a focus group with six clients of an 
addiction treatment centre, fi ve of whom had been addicted 
to a minor tranquilliser or sedative, and one to codeine. 
Alcohol was the main problem drug in all cases. The 
focus group revealed that none of the fi ve clients was 
aware of the risks of dependence on drugs when they were 
prescribed minor tranquillisers. It was also clear that it was 
easy to get a prescription and easy to have it repeated. None 
of the participants in the focus group had been offered 
alternative therapies. 
The author interviewed six addiction counsellors in HSE West 
Mental Health and 10 substance misuse counsellors in HSE 
West Drug Service. Both of these groups of service providers 
expressed broadly similar concerns. The issues raised were:
Inappropriate prescribing: Many people have • 
become dependent on minor tranquillisers and 
sedatives as a result of being maintained on them 
long after the optimum therapeutic period.
Individual choices in misuse: People prescribed • 
these drugs may not fully understand their addictive 
potential or the consequences of taking them 
incorrectly. In cases of alcohol and minor tranquilliser 
co-dependency, the emphasis in treatment is 
invariably on alcohol and it is diffi cult to deal with 
the addiction to the prescribed drug. Sharing of 
prescriptions among family members is also an issue.
Public policy and remuneration issues: Health • 
authorities and professional regulatory bodies have 
failed to take action to deal with the problem use 
of these drugs. Payment of professional fees from 
reimbursement schemes is not conditional on 
appropriate prescribing or dispensing.
Diversion and leakage: As a result of over-prescribing • 
of minor tranquillisers and sedatives, a large amount 
of these drugs become available for illicit use and this 
drives a thriving black market.
Key service issues: The counsellors agreed that only a • 
very small proportion of those who have an addiction 
actually present for treatment. The treatment fi gures 
do not provide a true picture of the problem.
The study concludes that there is excessive and 
inappropriate prescribing of minor tranquillisers and 
sedatives in the western region. Despite the introduction 
of good practice guidelines in 2002, spending on these 
drugs by the public health service doubled between 2000 
and 2007. The author points to the failure of this service to 
control three drivers of incorrect use: pricing, prescribing 
and distribution. There is limited control of distribution and 
prescribed drugs are easily diverted to the black market. 
There is very limited non-medical support to addicts and 
very little co-ordination between primary care, mental health 
and community service providers, making it more diffi cult to 
identify and deal with problem drug use.
The report makes a number of recommendations, 
including more rigorous regulation and tighter controls on 
distribution. Doctors and pharmacists need to be educated 
on the consequences of over-prescribing and on addiction-
related issues, and individuals need to be provided with 
better information to enable them to make informed 
decisions regarding their use of these drugs.
(Brian Galvin)
1. Flynn K (2009) Minor tranquillisers & sedatives: use and 
misuse in the west of Ireland. Galway: Western Region 
Drugs Task Force.
2. Minor tranquillisers and sedatives is the term used 
throughout the report to refer to a class of psychoactive 
substances that includes benzodiazepines and related 
drugs.
3. Department of Health and Children (2002) 
Benzodiazepines: good practice guidelines for clinicians. 
Dublin: Department of Health and Children.
4. The appointment of a GP and pharmacy liaison nurse in 
the region has resulted in a substantial increase in the 
number of cases reported to the NDTRS since 2006.
WRDTF area – tranquillisers and sedatives (continued)
Substance use in the Traveller 
community in the WRDTF area 
The Western Region Drugs Task Force (WRDTF) has 
published a report on the nature and extent of substance 
use, and use of services, by members of the Traveller 
community in the west of Ireland.1 This is the second in 
a series of three reports on substance use in the region 
commissioned by the WRDTF.
Data were collected from 57 focus groups that included 
both adult and younger members of the Traveller 
community. Interviews and consultations were held with 
45 service providers, including services dealing specifi cally 
with substance use among Travellers. The fi eldwork was 
complemented by prior consultation with stakeholders, 
desktop research and a literature review. 
Service providers reported a marked increase in problematic 
drug and alcohol use among Travellers in the last 10 years 
in the west of Ireland. Substance use was mainly seen as 
an escape from depression, poor health, diffi culties with 
employment and strained relationships with the settled 
drugnet 
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WRDTF area – Traveller community (continued)
Substance use in new communities in 
the WRDTF area 
The third in a series of three research reports commissioned 
by the Western Region Drugs Task Force (WRDTF) explores 
substance use among new communities in the west of 
Ireland and identifi es barriers to effective use of services.1 
New communities include migrant workers, refugees, asylum 
seekers, and migrants who have been granted citizenship. 
At the time of the 2006 census, there were 48,387 non-
nationals living in the west of Ireland. 
The authors state that members of new communities in 
Ireland come from countries where the rates of substance 
use among adults are generally lower than they are in this 
country. They note that Irish research and informal reports 
from service providers suggest that migrant workers and 
refugees and asylum seekers are not accessing health 
services in Ireland because of the high cost of these services, 
lack of insurance, unfamiliarity with the health system and 
poor English language skills. 
community. In terms of risk, older Travellers reported a fear 
of drugs and potential overdose, with younger Travellers 
indicating an acceptance of the use of drugs such as 
cannabis and ecstasy as relatively normal.
Alcohol 
According to service providers, alcohol remains the 
substance of most concern in this community, and 
increasing levels of use were reported among Traveller men 
and more recently among single Traveller women. Some 
Travellers were aware of ‘drink problems’ in their community, 
and reported that such problems were usually dealt with 
within the family. Service providers felt that because 
Travellers are discriminated against in certain pubs, they buy 
cheap alcohol from supermarkets, which contributes to high 
levels of consumption in the home and at halting sites. They 
reported that high levels of alcohol use can contribute to 
violence in the home and when family break-up occurs and 
‘the head of the house’ (usually the male) leaves the family 
home, the women often resort to alcohol and prescribed 
medication. 
Drugs 
Travellers commented that there are visibly ‘more drugs’ 
in urban areas in the west in the past two years, and that 
drugs are increasingly available in the region as a whole 
in comparison to the situation 10–15 years ago. Ecstasy, 
speed, hash and cocaine are the drugs most commonly 
used. Polysubstance use is common, most often in the 
following combinations: alcohol and hash/cannabis; alcohol 
and benzodiazepines; benzodiazepines and Solpadeine; 
Solpadeine and alcohol; cocaine and alcohol; Red Bull and 
Anadin; Zamadol and Coca-Cola; Anadin and Coca-Cola 
and painkillers and alcohol. According to service providers, 
Traveller males use hash, cocaine and ecstasy and Traveller 
women tend to use prescription medication. Despite some 
anecdotal reports of heroin (smoking), crack cocaine and 
cocaine use, the majority of service providers reported little 
direct evidence to suggest that these substances are widely 
used. 
Levels of illicit drug use among young Traveller women were 
perceived to be lower than those reported by young women 
in the general population. This was often attributed to the 
degree of monitoring, parental control and restriction of 
income of young women in Traveller communities. However, 
there were reports that young Traveller women use night 
sedation medication and benzodiazepines.
Drug dealing
Mixed views existed on the nature and extent of drug 
dealing in the Traveller community. The general consensus 
was that it exists but is not widespread and that users tend 
to obtain their drugs through their own families and have 
little contact with dealers in the settled community. Some 
Travellers were concerned that both Traveller and settled 
drug dealers were recruiting young Travellers to act as 
‘runners’ and were therefore also providing them with an 
introduction to drugs and context for use.
Drug awareness and information 
Travellers felt the level of drug awareness within their 
community was quite low. Older Travellers viewed illicit 
drugs as a sensitive and ‘taboo’ topic. The majority of 
Travellers who had participated in drug awareness training 
felt that it was not suitable for a Traveller group, as it was 
not based on their values and beliefs. The most pervasive 
theme was the importance of involving the Travellers in drug 
education and prevention, and taking into consideration 
their norms and cultural values in the delivery of such 
services and educational materials. It was remarked that 
Travellers ‘would prefer information from Travellers’.
This research is welcome and builds on what is already 
known about substance use in the Traveller community. 
The main fi ndings are similar to those of a 2006 study,2 and 
show that levels of illicit drug use among Travellers are low 
compared to those in the general population, particularly in 
the case of Class A drugs such as heroin and cocaine. This 
research shows the infl uence of informal ‘social controls’ 
that pertain in some Traveller communities. These informal 
mechanisms are often credited with reducing the use of illicit 
drugs among young Traveller women, but appear to be less 
effective in reducing the use of prescription and over-the-
counter drugs by young women. 
(Martin Keane)
1. Van Hout MC (2009) Substance misuse in the Traveller 
community: a regional needs assessment. Galway: Western 
Region Drugs Task Force. 
2. Fountain J (2006) An overview of the nature and extent 
of illicit drug use amongst the Traveller community: an 
exploratory study. Dublin: National Advisory Committee 
on Drugs.
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The authors report that risk factors for substance use in 
new communities are generally the same as those in other 
communities, and include mental health issues, social 
isolation, poor education levels and unemployment. For 
some members of new communities, post-traumatic stress 
disorder can interact with experiences of discrimination and 
social exclusion to increase the risk of substance use. Other 
factors include the strain of being undocumented, having 
illegal status, and anxiety about being discovered. Having 
limited access to medical services except in the case of an 
emergency can impede access to frontline services such as 
GPs where substance use may be identifi ed as a problem 
and treated early. 
According to this report, adolescents in new communities 
can experience isolation due to low levels of supportive 
peer relationships in school. Additional strain can occur for 
these young people when they learn new language and 
cultural practices which refl ect the norms of the indigenous 
population. This may result in a clash with the value system 
and cultural practices of their family. Taken together, these 
factors can increase the risk of substance use among young 
people as they try to fi t in with the indigenous culture and 
deal with social isolation. 
The authors interviewed by phone 18 statutory and 
voluntary groups involved in the support of new 
communities or the provision of substance use services 
to explore their perspective on substance use in these 
communities. Almost all those contacted had no specifi c 
or specialist information on the issue, nor did their 
organisations have policies or strategies to address the issue. 
This research included an analysis of regional press coverage 
of substance use issues in the west, and particularly in new 
communities, between 8 and 14 December 2008. The 
results suggest that there is more media interest in alcohol-
related issues than in other drug issues and that there is 
more ambivalence about alcohol (which is presented as 
both potentially dangerous and positive and worthy of 
promotion) than other drugs (which are presented entirely 
negatively). In relation to the issue at hand, only fi ve articles 
were identifi ed where members of new communities and 
alcohol or other drugs were explicitly linked, and just 
three of those cases concerned drug possession or public 
drunkenness.
This report mentions a small number of studies on 
appropriate responses to substance use in new communities. 
These are highlighted as potential ‘starting points’ for 
communication among service providers and, according 
to the authors, are ‘in a sense pragmatic and in some cases 
“best guesstimates” of what could work’. 
The authors uncovered little evidence of substance use as a 
substantial problem, or one that required immediate action, 
among new communities in the west of Ireland. However, 
the reluctance of members of new communities to access 
health services, as acknowledged in this report, suggests that 
the views of service providers as to the extent of substance 
use may not refl ect the true situation in the communities. 
Alternative methods of collecting primary data, such as 
training people from new communities to undertake in-
depth fi eldwork, including interviews and observation, may 
yield a different picture to that conveyed here. A 2004 study 
using these methods found that heroin and cocaine use 
were becoming a problem among some sections of new 
communities in Ireland.2 
(Martin Keane)
1. Kelly C, Fitzpatrick C and Nic Gabhainn S (2009) 
Substance use in new communities: a way forward. 
Galway: Western Region Drugs Task Force.
2. Corr C (2004) Drug use among new communities in 
Ireland: an exploratory study. Dublin: National Advisory 
Committee on Drugs.
Fourth ESPAD survey on substance use 
among young people
Mary Wallace TD, Minister of State at the Department of 
Health and Children, announced the publication of the 
fourth European School Survey Project on Alcohol and Other 
Drugs (ESPAD) on 26 March 2009.1 
ESPAD surveys have been conducted every four years 
since 1995, using a standardised method and a common 
questionnaire. The rationale for these surveys is that school 
students are easily accessible and are at an age when onset 
of substance use is likely to occur. (By defi nition, early school 
leavers, a group known to be vulnerable to alcohol and 
drug use, are not represented.) ESPAD survey information is 
valuable in planning prevention initiatives. 
The fourth survey was conducted in 35 European countries 
during 2007 and collected information on alcohol and illicit 
drug use among 15–16-year-olds; 2,249 students from 94 
randomly selected schools participated, which represents 
a response rate of 78%. Fewer schools and students 
participated in 2007 than in 2003. 
The 2007 survey report acknowledges that problems in 
the wording of the questionnaire affected the comparability 
of Irish data in relation to beer and cider consumption, 
and in relation to binge drinking.2 Consequently, this 
report does not contain Irish data on the volume of alcohol 
consumed on the last drinking occasion or the frequency of 
binge drinking. 
In terms of alcohol consumption, the Irish data show unusual 
trends in both alcohol use and drunkenness. Drunkenness 
increased between the 1995 and 2003 surveys, but 
decreased considerably in 2007 (Figure 1). The percentage 
of students who had consumed any alcohol in the past 30 
days decreased between 2003 and 2007 (from 73% to 
56%), while the percentage who had been drunk in the 
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previous 30 days halved (53% in 2003, 26% in 2007). The 
2007 European average for alcohol consumption in the last 
30 days was 61% (5 percentage points higher than Ireland), 
while the European average for drunkenness in the last 30 
days was 18% (8 percentage points lower than Ireland). 
Figure 1 Alcohol use and drunkenness among school-going children (15–16 years) in Ireland as reported to the 
ESPAD surveys of 1995, 1999, 2003 and 2007
 *Binge-drinking data unavailable for 2007
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In terms of drug use, the Irish data show a marked decrease 
in lifetime use of any illicit drug between 2003 (40%) and 
2007 (22%),a fall of 18 percentage points (Table 1). As 
the majority of those who have tried any illicit drug have 
used cannabis (marijuana or hashish), the decrease in illicit 
drug use was infl uenced by the considerable decrease in 
the number of students who had tried cannabis at some 
point in their lives, from 39% in 2003 to 20% in 2007 
(European average 19%). Lifetime use of solvents/inhalants 
decreased from 18% in 2003 to 15% in 2007, but remained 
higher than the European average (9%). In the case of 
both amphetamines and cocaine powder, the proportions 
reporting lifetime use increased marginally to just above 
the European average of 3%. In 2007, one in ten of the 
survey participants reported that they had taken prescribed 
tranquillisers or sedatives at some point in their lives; the use 
of such drugs had decreased marginally since 1999. 
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In another national study, the HBSC (Health Behaviour 
in School-aged Children) survey,3 lifetime cannabis use 
among 15–17-year-olds was 29% in 2006 compared to 
26% in 2002 and 25% in 1998 ( S Nic Gabhainn, personal 
communication, 2008). The HBSC survey shows a steady 
marginal increase in cannabis use between 1998 and 2007, 
whereas the ESPAD survey shows a large increase between 
1999 and 2003 and a larger, unexpected decrease between 
2003 and 2007 (Figure 2). It is important to investigate the 
reasons for the fall in alcohol and cannabis use reported in 
the ESPAD surveys; it could represent a genuine decrease in 
the use of alcohol and cannabis or a change in the type of 
sample chosen or the way the questionnaire 
was administered. 
Table 1 Proportions of school-going children (15–16 years) in Ireland who reported lifetime use of drugs in the ESPAD 
 surveys of 1995, 1999, 2003 and 2007
1995
(%)
1999
(%)
2003
(%)
2007
(%)
Lifetime use
Any illicit drug* 37 32 40 22
Cannabis 37 32 39 20
Inhalants (solvents) n.a. 22 18 15
Ecstasy 9 5 5 4
Cocaine powder 2 2 3 4
Amphetamines 3 3 1 3
Prescribed tranquillisers or sedatives n.a. 11 10 10
Non-prescribed tranquillisers or sedatives 7 5 2 3
*includes amphetamines, cannabis, cocaine, crack, ecstasy, heroin and LSD or other hallucinogens
n.a. = not available 
Figure 2 Trends in lifetime cannabis use, as reported by the ESPAD and HBSC surveys at three time points
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ESPAD survey results (continued)
Evaluation of work with marginalised 
youth
The Offi ce of the Minister for Children and Youth Affairs 
(OMCYA) established an Inclusion Programme in December 
2007 aimed at engaging margnalised young people in 
‘youth participation structures and processes’. Seven 
organisations were allocated funding to support such 
involvement by the young people they represented. An 
independent evaluation of the fi rst year of the Inclusion 
Programme has now been published.1 
The seven participating organisations and the number of 
participants from each organisation involved in the Inclusion 
Programme and other youth participation projects are 
shown in Table 1. Grants were offered to these organisations 
so that they could help young people become involved in 
structures such as the Children and Young People’s Forum 
(CYPF)2 and Comhairle na nÓg.3 These structures provide a 
mechanism whereby the views of young people are sought 
on issues relevant to them, such as recreation policy and 
youth cafés. 
Table 1 Number of young people involved in the Inclusion Programme and other youth participation structures, 
 per participating organisation
Inclusion 
Programme
Other participation 
structures
Total
Barnardos 2 0 2
BeLonG To Youth Service (an organisation for lesbian, 
gay, bisexual and transgendered (LGBT) young people) 1 2 3
Ferns Diocesan Youth Service (FDYS) 37 10 47
Inclusion Ireland (National Association for people with 
an intellectual disability) 2 0 2
Irish Association of Young People in Care (IAYPIC) 4 0 4
Irish Wheelchair Association (IWA) 12 1 13
Pavee Point (Traveller organisation) 10 5 15
Total 68 18 86
Source: McEvoy 2009
Programme evaluation and data collection methods
Site visits were made to six of the organisations and the 
evaluator conducted face-to-face interviews and a number 
of telephone interviews with key stakeholders in all seven 
organisations, including 21 young people, and 11 adults 
who were youth leaders, project leaders, steering committee 
representatives or directors of the organisations. Each 
organisation submitted two progress reports during the fi rst 
year of operation. 
Level of participation by young people 
Sixty-eight young people were involved in projects 
specifi cally relating to the Inclusion Programme and a 
further 18 were involved in other youth participation 
structures. More than half of the total number is accounted 
for by the high numbers attending the Ferns Diocesan Youth 
Service in Wexford. The evaluator states that the numbers 
involved are a ‘simple and important criterion’ of success; 
however, it must be noted that in most cases the numbers 
were small. This may refl ect the ‘bedding down’ time it 
takes to initiate this type of intervention and to attract 
marginalised young people. 
Key fi ndings from evaluation
The young people interviewed identifi ed the benefi ts 
of participation in the Inclusion Programme and other 
youth participation projects in terms of opportunities – to 
get involved; to have a voice; to make new friends and 
understand different points of view; to improve personal 
skills, such as communication, confi dence and team 
(Jean Long and Deirdre Mongan)
1. Hibell B et al. (2009) The 2007 ESPAD report: substance 
use among students in 35 European countries. Stockholm: 
The Swedish Council for Information on Alcohol and 
Other Drugs (CAN) and the Pompidou Group of the 
Council 
of Europe.
2. These anomalies are explained in the report (pp. 224–
225), and concern the fact that Ireland uses both metric 
and imperial measures (litres/pints) and has a wide 
variety of containers for beer and cider (ranging from 
284 ml to 568 ml), the absence of one answer category 
in the question about spirits consumption, and the lack 
of a defi nition of ‘a drink’ in the binge-drinking question.
3. The HBSC (Ireland) survey is conducted every four years 
by a research team at the Health Promotion Research 
Centre at the National University of Ireland, Galway, in 
collaboration with the WHO Regional Offi ce for Europe 
(see www.nuigalway.ie/hbsc).
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working; and to feel a sense of achievement. The evaluation 
notes that the personal stories of the young people are 
testament to a programme that was well organised, well 
supported and meaningful and the ultimate benefi t was that 
young people felt empowered and valued in the projects, as 
refl ected in comments such as: ‘you are not judged on your 
background’ and ‘ people don’t treat you differently’.
The evaluator states that the achievements of this 
programme represent progress in a short space of time. 
However, continued commitment and drive is required 
from the OMCYA and participating organisations to ensure 
that young marginalised people continue to benefi t from 
engaging in youth participation structures, and that such 
structures benefi t from integrating the views of young 
people on issues affecting their lives. 
(Martin Keane)
1. McEvoy O (2009) Evaluation report on the inclusion 
programme. Dublin: Offi ce of the Minister for Children 
and Youth Affairs. 
2. The Children and Young People’s Forum (CYPF) was 
established in 2004 to advise the OMCYA and the 
Minister for Children on issues of concern to children 
and young people. Thirty 12–18-year-olds from all over 
the country participate in the Forum.
3. Comhairle na nÓg is a network of local youth councils 
which give children and young people the opportunity 
to be involved in the development of local services 
and policies.
Work with marginalised youth (continued)
A new model of progression for 
recovering drug users 
The Working Group on Drugs Rehabilitation1 recommended 
that factors that make it diffi cult for recovering drug users 
to access education should be identifi ed and removed 
where possible. Soilse, the addiction rehabilitation service 
of the Health Service Executive (HSE), has been involved in 
identifying obstacles to further education for clients for quite 
some time. During this work a recurring theme emerged 
in relation to clients who were attending mainstream 
educational institutions. Because of negative experiences of 
the education system when they were young, many clients 
of Soilse do not have the necessary ‘educational capital’ to 
engage actively with the demands of academic study. The 
average school-leaving age of Soilse participants is 15.5 
years; many have pronounced literacy diffi culties and almost 
all are dependent on social welfare.2
To address this issue, Soilse, in collaboration with NUI 
Maynooth, developed a Return to Learning (RTL) 
programme to empower and support former Soilse 
participants to tackle these obstacles and progress to further 
education. Using an integrated literacy approach, the RTL 
programme sought to prepare a group of 12 participants 
for college by simulating college conditions and providing 
technical, personal development, group-based learning, 
study and time management skills, and knowledge transfer. 
The pilot ran from June to September 2008 and was 
funded by the HSE, the City of Dublin Vocational Education 
Committee (CDVEC) and FÁS. 
The rationale behind the RTL programme was twofold. First, 
and most important, it enabled participants to develop 
the skills and confi dence to undertake, enjoy and succeed 
in a post leaving cert (PLC), institute of technology or 
university course. Second, it provided a ‘structure’ from the 
time participants completed Soilse’s six-month drug-free 
programme until their third-level course started, typically 
in September.
In Soilse’s experience, it is vital for people in early recovery 
to have a structure in their daily lives – something to do 
each day and somewhere to be. Without this, people are 
more likely to slip into old patterns of behaviour or social 
networks, with the risk of relapse. Taking up employment 
while waiting to start college is generally not an option 
as this can affect participants’ eligibility for the Back to 
Education Allowance (BTEA), and Vocational Training 
Opportunities Scheme (VTOS) and Higher Education 
Authority (HEA) grants.
Feedback from RTL participants was that the programme 
met their personal and learning needs. They found the 
requirements around time-keeping, attendance, studying 
and completing assignments challenging but they gained 
technical skills in structuring assignments, sourcing 
information, using computers and becoming familiar with 
material they would encounter in college. They also made 
personal gains in becoming more refl ective, self-assured, 
analytical and realistic about college expectations.
At a three-month follow-up, eight of the 12 RTL participants 
were enrolled in PLC courses, one was in Trinity College’s 
Access Programme, one was working and studying 
part-time, one was awaiting a FÁS course and one was 
unemployed. All reported that they were not using drugs. 
This high success rate indicates how a targeted and 
supportive educational skills development programme can 
help former drug users to overcome the barriers to social 
integration. From Soilse’s perspective, the RTL programme 
provided an excellent and cost-effective use of once-off 
funding, enabling participants to progress into education, 
which is a bridgehead to career independence. 
This pilot represents an important advance in understanding 
the obstacles to education for recovering drug users and in 
identifying how to respond effectively to these challenges. 
In particular, the lessons learned from this pilot can serve 
as an important contribution to the implementation of 
the recommendations of the Working Group on Drugs 
Rehabilitation regarding education for recovering drug users.
(Sandra Burke and Martin Keane)
1. Working Group on Drugs Rehabilitation (2007) National 
Drugs Strategy 2001–2008: Rehabilitation. Dublin: 
Department of Community, Rural and Gaeltacht Affairs. 
2. Information supplied by Soilse (www.soilse.ie).
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Family Support Network re-launched 
The Family Support Network (FSN) was launched as an 
independent national organisation at a ceremony in Dublin’s 
Mansion House on 26 March. Speaking at the launch, Sadie 
Grace, FSN Coordinator, highlighted the role of family 
support services in dealing with the problem of drug use. 
‘These services need adequate funding and resources if they 
are to develop’, she said. 
John Curran TD, Minister with responsibility for drugs 
strategy, paid tribute to the staff and management 
committee of FSN and said ‘It is clear that the Network has 
put immense effort into the provision of vital information 
and support to members, families and communities.’ 
Professor Des Corrigan, Chairperson of the National 
Advisory Committee on Drugs, spoke of FSN's progress 
from a small number of groups, mainly in Dublin, to a 
nationwide organisation and congratulated family members 
on their commitment and dedication since the network was 
established in 2000. Marian Davitt, a founding member 
of the FSN group in Bray, highlighted the benefi ts family 
members received from attending the group. 
Also attending the launch were the Lord Mayor of Dublin, 
Councillor Eibhlin Byrne, Archbishop Diarmuid Martin, and 
Chief Superintendent John O’Driscoll, representing Garda 
Commissioner Fachtna Murphy.
FSN now has its own premises in a central Dublin location. 
The new website, www.fsn.ie, will provide accurate 
information for families who want to learn about addiction, 
its effect on the family and the supports that are available for 
families. It will also act as a resource for new and established 
family support groups and networks. 
(Brian Galvin)
For further information contact Sadie Grace at FSN: 
(01) 8365 168 / (087) 983 4810.
Women speak about their drug-related 
problems
To mark International Women’s Day (8 March), the EMCDDA 
published a collection of narratives from women facing 
drug-related problems.1 While it is estimated that, in Europe, 
around one in four drug users entering treatment is female 
and women account for one in fi ve drug-related deaths, 
most drug services in Europe are designed with male drug 
users in mind. The EMCDDA’s new thematic paper presents 
quotations gleaned from interviews conducted between 
2000 and 2008 with women in eight EU member states. 
They illustrate how qualitative research can yield insights 
into the experiences and perceptions of women facing drug 
issues that statistics alone cannot provide and that can help 
in designing services that better meet the needs of a sizeable 
proportion of clients. 
The thematic paper identifi es fi ve key issues.
The confusion and desperation that mothers experience 1. 
when their own children develop drug problems.
The deprivation and abuse that characterise the lives of 2. 
many women who develop drug problems.
The diffi culties faced by drug-using women who attempt 3. 
to fulfi l societal roles as mothers and provide the sort of 
childcare they and ‘society’ wish for children.
The plight of women drug users in prison — the most 4. 
vulnerable of all women.
Stigma, policies and practices that make it diffi cult for 5. 
women to access treatment.
In a previous EMCDDA report, which undertook a gender-
based analysis of quantitative data on drug use and 
responses to drug problems in EU member states, it was 
concluded that ‘policymakers, professionals and scientists 
must always take gender into consideration in the planning 
of research, analysis, interventions and policy in the drugs 
fi eld.’2 Using qualitative data, this new thematic paper spells 
out just how interventions for female drug users might 
be tailored: 
… there is a need for holistic interventions for female 
drug users. … the overarching theme illustrated by 
the quotations is about the struggle that female drug 
users face in fulfi lling their social roles. Some of their 
quotations are invocations for improved services to 
alleviate their drug problems and provide them with 
necessary social support but it is important to recognise 
that other quotations are invocations for fi nding ways 
to reduce the stigma imposed on them and recognising 
their achievements in controlling their drug use and 
fulfi lling their social roles. (p. 18)
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At the launch were (l to r) Minister of State John Curran 
TD, Sadie Grace of FSN, Archbishop Diarmuid Martin 
and Lord Mayor of Dublin, Councillor Eibhlin Byrne 
(Photo: courtesy Lord Mayor’s Offi ce)
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The EMCDDA did not use Irish sources in compiling this 
thematic paper. However, a number of studies of the drug 
problem in Ireland have included qualitative data on Irish 
women’s experiences and perceptions of their drug-related 
problems. The authors of these studies have highlighted 
their potential to inform policy decisions. A selection of these 
studies is listed below. 
(Brigid Pike)
Women and drug-related problems (continued)
Recent studies containing qualitative data on the 
experiences and perceptions of Irish women facing drug-
related problems3
Comiskey CM, O’Sullivan K and Cronly J (2006) • 
Hazardous journeys to better places: positive 
outcomes and negative risks associated with the care 
pathway before, during and after an admittance to 
the Dóchas Centre, Mountjoy Women's Prison, Dublin, 
Ireland. Dublin: Health Service Executive. 
Coveney E, Murphy-Lawless J, Redmond D and • 
Sheridan S (1999) Prevalence, profi les and policy: 
a case study of drug use in north inner city Dublin. 
Dublin: North Inner City Drugs Task Force. 
(Includes an extended case study interview with a 
26-year-old recovering female addict.)
Hunter P (2004) An investigation into the lifestyle, • 
risk behaviours and health care needs of street-
based female prostitutes in Belfast, Northern 
Ireland. PhD Thesis, University of Ulster.
Lawless K and Wayne A (2005) • The Next Step 
Initiative: research report on barriers affecting women 
in prostitution. Dublin: Ruhama.
 Lawless M (2003) Private lives – public issues: an • 
investigation into the health status of female drug 
users. In Pieces of the jigsaw: six reports addressing 
homelessness and drug use in Ireland. Dublin: 
Merchants Quay Ireland. 
Murphy-Lawless J (2002) • Fighting back: women 
and the impact of drug abuse on families and 
communities. Dublin: Liffey Press.
O’Kelly EM (2005) Study on the perceptions • 
of female drug users in relation to the 
consequences of parental substance abuse on the 
children of the substance misusers. MSc Thesis, 
Dublin City University. 
Woods M (1999) Women, drug use and parenting • 
in Dublin: the views of professional workers in 
the drug treatment and social work fi elds. Paper 
presented at 10th annual European Society for the 
Study of Drug Use (ESSD) Conference on Drug 
Use and Drug Policy in Europe, held in Vienna in 
September 1999. 
1. EMCDDA (2009) Women’s voices: experiences and 
perceptions of women who face drug-related problems in 
Europe. Thematic paper. Luxembourg: Offi ce for Offi cial 
Publications of the European Communities. 
2. EMCDDA (2006) A gender perspective on drug use and 
responding to drug problems. Selected issue. Luxembourg: 
Offi ce for Offi cial Publications of the European 
Communities. Ireland’s input to this selected issue is 
contained in the 2005 Annual Report to the EMCDDA, 
which may be accessed at www.ndc.hrb.ie (Drugs in 
Ireland page).
3. This selection is taken from the electronic database 
administered by the National Documentation Centre 
on Drug Use (NDC) at www.ndc.hrb.ie. On 23 March 
2009, a search of the database was undertaken, using 
the keyword ‘women’; 121 items were retrieved, 96 of 
which were general reviews, research reports and policy 
documents relating to substance misuse, including 
alcohol and tobacco, in Ireland. The majority of the 
research reports described quantitative studies of, for 
 example, the epidemiology of female problem drug use, 
risk behaviours, infectious diseases, homelessness and 
comorbidity among cohorts of female drug users, and 
the effects of drug use on pregnancy. Among the small 
number of reports containing qualitative data, a selection 
of those published in the last 10 years is listed here. 
For a survey of earlier Irish research studies, including 
qualitative studies, see E Farrell (2001) Women, children 
and drug use. In R Moran et al. A collection of papers on 
drugs issues in Ireland. Dublin: Health Research Board. 
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Mental health and well-being of LGBT 
people – the role of alcohol and drugs
On 2 February 2009 an exploratory study of the mental 
health and well-being of lesbian, gay, bisexual and 
transgender (LGBT) people in Ireland was published. 
Commissioned by the Gay and Lesbian Equality Network 
(GLEN) and BeLonG To Youth Services, and funded by 
the Health Service Executive’s National Offi ce for Suicide 
Prevention, the research was undertaken by a team of 
researchers from TCD, UCD and UCC.1 
The purpose of the study was to examine mental health 
and well-being, including an investigation of suicide 
vulnerability (risk) and resilience, among LGBT people in 
Ireland, and to make recommendations on policy, service 
delivery and practice related to mental health promotion 
and suicide prevention. 
The researchers used the ‘minority stress model’ to aid 
their understanding of the negative impacts on health and 
well-being caused by a stigmatising social context. External 
stressors were found to include presumed heterosexuality, 
homophobia, prejudice and victimisation; internal stressors 
related to the anxiety of coming out. Negative reactions 
from others when an individual ‘came out’ to them also 
featured, as did the stress of self-concealment.
The fi ndings on mental health indicators suggested that the 
stigma and discrimination encountered by LGBT people can 
result in an extremely negative experience of being LGBT. 
Many participants in the study described having experienced 
depression, and a signifi cant minority reported engaging 
in self-injurious behaviour, including hazardous drinking or 
problem alcohol use, and suicidal thoughts.
The ‘resilience narratives’ of LGBT individuals were explored, 
with special reference to self and others, and also in relation 
to the social environments or contexts where LGBT people 
interact. Four key sources of social resilience were discerned 
– friends, family, the LGBT community, school and the 
work place. 
With regard to ‘self-resilience’, the researchers found 
evidence to suggest that resilience is an ongoing and 
emerging process rather than simply a trait possessed 
by some LGBT individuals and not by others. Positive life 
experiences and turning points were observed to have led 
to greater self-esteem and self-effi cacy among participants. 
Many also identifi ed ‘coping strategies’ that they used 
to alleviate stress. Six of the 20 coping strategies listed in 
the survey instrument related to the use of licit and illicit 
substances, and participants (N=1,110) identifi ed using 
these strategies as follows: 
drink alcohol to get drunk 28.2% (n=313)• 
drink alcohol (not to get drunk) 25.5% (n=283)• 
smoke cigarettes 24.5% (n=272)• 
take medication prescribed by a doctor/psychiatrist • 
(e.g. anti-depressants) 17.3% (n=192)
take prescription drugs (without advice of a doctor or • 
medical worker) 12.3% (n=136)
take illegal drugs 10.0% (n=111)• 
The researchers concluded that social and structural factors 
play a signifi cant role in determining the mental health of 
LGBT people. Their recommendations therefore focused 
on measures to achieve institutional and social change. 
For example:
the needs of LGBT people should be integrated into • 
all health policies and strategies, including policies 
and strategies on alcohol and drug (mis)use;
health, mental health and social services should be • 
provided in a way that is accessible and appropriate 
to LGBT people;
specifi c attention should be paid to the needs of • 
transgender people within health policy;
health professionals should be trained both to • 
understand how an LGBT identity is a potential 
risk factor for self-harm, suicidal behaviour and 
depression, and to have cultural competency specifi c 
to the LGBT population;
LGBT-specifi c groups and organisations nationally, • 
and front-line responses such as the voluntary 
LGBT helplines throughout the country, should be 
resourced to engage in mental health promotion and 
suicide prevention work.
The researchers identifi ed opportunities for positive 
intervention and change at the personal and interpersonal 
levels in the education and youth-work sectors, and within 
families. They recommended, for example, increasing the 
recognition of LGBT needs and issues in the SPHE (Social, 
Personal and Health Education) curriculum and in early-
school-leaving policies and programmes, and increasing 
awareness, training and resourcing of teachers, youth 
workers and family members who work with LGBT young 
people, in order to ensure they can support them in 
developing confi dence and self-esteem.
With regard to research, the authors recommended that, 
in future, all national administrative databases, general 
population surveys, and longitudinal and other large-scale 
survey research on children, young people and families 
should, as a matter of course, include items that can capture, 
or questions on, sexual orientation, gender identity and 
same-sex partnership and cohabitation. 
(Brigid Pike)
1. Mayock P, Bryan A, Carr N and Kitching K (2009) 
Supporting LGBT lives: a study of the mental health and 
well-being of lesbian, gay, bisexual and transgender people. 
Dublin: National Offi ce for Suicide Prevention. Retrieved 
on 25 April 2009 at www.tcd.ie/childrensresearchcentre. 
The research adopted a multi-modal approach, including 
the administration of a primarily quantitative on-line 
survey, and the conduct of a community assessment 
process and of in-depth individual interviews with 40 
individuals who identifi ed as LGBT. 
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Alcohol’s role in traumatic brain injury
A recent study has reported that alcohol is associated with 
one in four traumatic brain injuries (TBIs) in Ireland.1 Trauma 
is the leading cause of death in Irish people aged under 
45, and for every traumatic brain injury death at least two 
people survive with a permanent disability, which has as yet 
unmeasured personal, societal and economic consequences.
This study analysed the records of 2,095 patients attending 
the two neurosurgical units in Ireland – Beaumont Hospital 
and Cork University Hospital – over a two-year period. Men 
were three times more likely to be injured than women and 
one in six patients was aged between 16 and 24 years. 
Factors contributing to TBI, including alcohol and drug 
use, were studied. Alcohol was involved in one in four TBIs. 
However, there was inadequate recording of alcohol use in 
60% of medical notes, and 85% had no data on drug use. 
Only 1.3% of patients were documented as having used 
recreational drugs prior to sustaining their injury. 
Table 1 Involvement of alcohol in TBI, by accident type
 
Accident type Alcohol involved
Fall 24%
Injury at home 27%
Road user injury 21%
Alleged assault 59%
Sports injury 7%
All types 24%
The authors’ recommendations include introducing 
awareness strategies to highlight the increased risk of serious 
injury associated with alcohol use. The report also suggested 
that drug use and its impact on TBIs is an area which needs 
improved documentation and further exploration. 
(Deirdre Mongan)
1. Traumatic Brain Injury Research Group (2008) National 
report on traumatic brain injury in the Republic of Ireland 
2008. Phillips report. Dublin: Traumatic Brain Injury 
Research Group.
RADE launches debut ﬁ lm, Today 
RADE, a drug recovery project, launched their short fi lm, 
Today, followed by a ‘behind the scenes’ documentary on 
26 May 2009 in the Irish Film Institute in Temple Bar. The 
fi lm tells the story of Patrick, who is sent by his eccentric 
doctor to fi nd an arts project in Dublin’s inner city. Today is 
an engaging, funny and moving short fi lm that introduces 
both Patrick and the audience to the colourful characters 
that have found a home in the ‘Art Row Workshop’. The fi lm 
was written and directed by Pom Boyd in collaboration with 
RADE participants. 
The Minister of State with responsibility for drugs strategy, 
John Curran TD, attended the launch. The Minister, a fan of 
the arts himself, highlighted the importance of rehabilitation 
and the need to perceive the rehabilitative process as much 
more than just a medical intervention but as a process of 
rebuilding lives through participation in projects such as 
RADE. Michael Egan, RADE’s project manager, underlined 
how projects such as Today were needed to counter the 
negative stereotype of drug users – people with drug 
problems can and do make positive contributions to society. 
It is hoped to screen the fi lm over the next 12 months at 
different venues and projects around the country. 
(Anne Marie Donovan)
For further information about RADE, see www.rade.ie; email 
info@rade.ie
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(cast members) during the Q & A session at the RADE 
event. (Photo: courtesy RADE)
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Reports examine effects of 
decriminalisation of drugs in Portugal 
Guidelines on ‘quasi-compulsory’ 
treatment 
Quasi-compulsory treatment (QCT) refers to any form of 
drug treatment that is ordered, motivated or supervised 
by the criminal justice system. The Council of Europe’s 
Pompidou Group (Criminal Justice Platform) commissioned a 
survey to ascertain what existing guidelines were employed 
by various jurisdictions when making QCT orders or 
recommendations for adult drug-dependent offenders.1 Of 
the 35 Council of Europe states requested to participate, 22 
countries (including Ireland) provided responses. 
Three-quarters (16) of the responding countries had national 
legislation in place to govern the implementation of QCT 
measures (Ireland was not one of these countries). Of 
these 16 countries, fi ve had adhered to all or most of 13 
established best practice principles and only one adhered 
to no such guidelines. Best practice principles related to 
eligibility, compliance monitoring, client rights, funding, 
programme objectives and treatment philosophy. Specifi c 
national guidelines for QCT, aimed at informing both health 
and criminal justice professionals, existed in 11 countries 
(not including Ireland). These national guidelines related 
to different stages of the criminal justice process, including 
arrest, court (pre-sentence), prosecution, imprisonment 
and post release. Eight of these jurisdictions had developed 
guidelines to evaluate the use of QCT. 
On the whole, the results of the survey were deemed 
encouraging but the variety of approaches among member 
states suggested the need to develop a transnational set 
of guidelines on QCT practices. It was also concluded 
that there was scope for legislation in the six responding 
countries (including Ireland) where legislation was absent. 
Of these countries, several had prison systems operating at 
or above capacity. 
The primary form of QCT available in Ireland is that offered 
by the Irish Drug Treatment Court (DTC). The DTC, 
established as a permanent court in 2006 after a fi ve-year 
pilot phase, deals with offenders who have either pleaded 
guilty or been convicted of minor crimes committed as 
a consequence of drug abuse. Addressing a European 
conference on QCT and other alternatives to imprisonment 
in October 2007, Judge Bridget Reilly of the DTC said: 
‘Despite the low graduation numbers, the progress and 
improvement in quality of life for the participants is seen 
to be very signifi cant by the DTC team, considering 
the background of low literacy skills, low educational 
participation, and often diffi cult social and family history.’2 
The DTC was due to be expanded to other areas under 
the National Drugs Strategy 2001–2008, which is currently 
under review. 
(Anne Marie Donovan and Johnny Connolly)
1. McSweeney T (2008) Guidelines on the ‘quasi-compulsory’ 
treatment of adult drug dependent offenders: results from a 
survey of Council of Europe member states. London: Kings 
College. Available at www.coe.int/t/dg3/pompidou/
2. Connolly J (ed.) (2007) The Irish drug treatment court – 
a view from the bench. Drugnet Ireland, (24): 22. 
Portugal became the fi rst country in the European Union to 
decriminalise all drugs, including cocaine and heroin, under 
a statute passed in 2000.1 Although drug possession for 
personal use and drug usage itself are still legally prohibited 
in Portugal, violations of these prohibitions are deemed 
exclusively administrative violations and are removed from 
the criminal process. Drug traffi cking continues to be 
prosecuted as a criminal offence. The law, according to a 
report commissioned by the Beckley Foundation,2 ‘formed 
part of a strategic approach to drug use which aimed to 
focus police resources on those people who profi t from the 
drugs trade, while enabling a public health approach to drug 
users’ (p. 2). A recent analysis of the legal reforms by the US-
based Cato Institute3 has concluded that ‘judged by virtually 
every metric, the Portuguese decriminalization framework 
has been a resounding success’ (p. 2).
Although several EU states have developed either formal or 
de facto forms of de-penalisation, particularly for personal 
cannabis use, whereby offenders seldom receive custodial 
sanctions, no EU state except Portugal has explicitly 
decriminalised drugs. Under the statute, decriminalisation 
applies to the consumption, purchase and possession of all 
drugs for ‘one’s own consumption’, which is defi ned as a 
quantity ‘not exceeding the quantity required for an average 
individual consumption during a period of ten days’ (Article 
2). No distinction is made between drug types or between 
public and private consumption. 
The statute establishes Commissions for the Dissuasion of 
Drug Addiction (CDTs) to adjudicate and impose appropriate 
sanctions for violations of the new law. The CDTs comprise 
three members appointed jointly by the ministries of justice 
and health and the government’s co-ordinator of drug 
policy, whereby one will have legal training and at 
least one of the other two will have a medical or social 
services background. 
Article 15 sets out the authorised administrative sanctions, 
which can include warnings and/or fi nes of an amount 
between €25 and the minimum wage. In the absence of 
evidence of addiction or repeated violations, the imposition 
of a fi ne is to be suspended. The CDT can also suspend 
sanctions on condition that the offender attends treatment. 
The Cato report points out that it is diffi cult to enforce such 
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Decriminalisation in Portugal (continued)
conditions in practice ‘since violations of a commission’s 
rulings are not, themselves, infractions of any law’ (p. 3).
Where offenders are deemed to be addicted to drugs, the 
CDT can impose a range of other sanctions, including, as 
summarised in the Cato report, ‘suspension of the right to 
practise a licensed profession (doctor, lawyer, taxi driver); 
a ban on visiting high-risk locales (nightclubs); a ban 
on associating with specifi ed individuals; ... prohibitions 
on travel abroad’ (p. 4). In determining the appropriate 
sanction, the CDT must consider factors such as ‘the 
seriousness of the act; the type of drug consumed; whether 
consumption was public or private; and whether usage is 
occasional or habitual’ (p. 4). However, providing drugs to 
a minor (or to a person with mental illness) is considered 
an aggravating factor under the general prohibition of 
traffi cking, which is punishable by imprisonment of between 
four and 12 years. 
Police offi cers who observe drug use or possession are 
required to issue citations to the offender, but they are not 
permitted to make an arrest. The citation is sent to the 
CDT and the administrative process then commences. The 
Cato report notes that the reaction of police offi cers to the 
initiative has been mixed, with some believing that ‘the 
issuance of citations, without arrest or the threat of criminal 
prosecutions, is worthless’ (p. 4), while other offi cers are 
now more inclined to act when they see drug use because 
they believe the new regime and the types of treatment it 
offers are a more effective response to personal drug use. 
The Beckley Foundation report described the nature of the 
support for the latter view: 
The law enforcement sector was seen as supportive 
of the reform, particularly because they perceived 
decriminalization and referral to education and 
treatment as offering a better response to drug users 
than under the previous legislative approach. Key 
informants asserted law enforcement have embraced the 
more preventative role for drug users. (p. 6)
According to the Cato report, there were 3,192 CDT 
rulings in Portugal in 2007. Of these, 83% suspended the 
proceedings; 15% imposed actual sanctions; and 2.5% 
resulted in absolution or dismissal. Cannabis continues 
to be the substance for which the greatest percentage of 
drug offenders are cited. Despite fears expressed by those 
opposing the reform prior to 2001, decriminalisation has 
not led to an increase in drug use. On the contrary, lifetime 
drug prevalence rates have decreased in Portugal since the 
reform. For the critical age groups of 13–15 years and 16–18 
years, ‘prevalence rates have declined for virtually every 
substance since decriminalization’ (p. 12). Furthermore, the 
author links a fall in the numbers of new cases of drug-
related HIV and AIDS, hepatitis B and C infection, and drug-
related death to the coming into effect of the law in 2001. 
Although he acknowledges that these trends started prior to 
2001 and were due in part to education reforms and harm 
reduction initiatives introduced in Portugal, he suggests that 
the removal of the fear and stigma of arrest and prosecution 
incentivised drug users to avail of these new treatment and 
education initiatives.
The analysis by the Beckley Foundation sounds a more 
cautious note, which probably accurately refl ects the current 
debate about decriminalisation in Portugal: 
Decriminalization has enabled earlier intervention and 
more targeted and therapeutic responses to drug users, 
increased collaboration across a network of services and 
increased attention to adopting policies that work. … 
Yet, key informants also highlighted that impacts were 
less than expected and that there were concerns over 
the message that decriminalization was sending to new 
drug users. 
(Johnny Connolly)
1. Law 30/2000 of 16 November 2000 came into force in 
Portugal on 1 July 2001. Published online in the offi cial 
gazette, Diário da República (DR), No. 276, pp. 6829–
6832.
2. Hughes C and Stevens A (2007) The effects of 
decriminalization of drug use in Portugal. Briefi ng paper 
14. Oxford: The Beckley Foundation. Available at www.
beckleyfoundation.org 
3. Greenwald G (2009) Drug decriminalization in Portugal: 
lessons for creating fair and successful drug policies. 
Washington DC: Cato Institute. www.cato.org 
A report on global illicit drug markets
One of the most comprehensive reports on the global 
illicit drug market was recently published by the European 
Commission. The report was researched and written by an 
international team of experts and timed to coincide with 
and inform the 2009 session of the Commission on Narcotic 
Drugs in Vienna.1 Specifi cally, the study sought to determine 
whether progress had been made in relation to the UN 
General Assembly (UNGASS 98) declaration and action plans 
aimed at rolling back drug abuse and traffi cking worldwide. 
Data were collected from 18 countries, including western, 
developing and so-called transitional states. The study 
employed a largely economic approach and looked at the 
drugs issue as if it were a licit market. It concludes, rather 
pessimistically, that ‘the relationship between drug policy 
and changes for the better in drug use or drug problems is 
marginal at best. The strongest evidence for this conclusion 
is the marked similarity in drug trends in countries with very 
different drug policies’ (p. 21). 
As well as the main report Assessing changes in global drug 
problems 1998–2007, the work contains six sub-reports and 
18 country reports.2 The sub-reports cover the following 
topics:
The operation of the global drug market ■
Estimating the size of the global market:  ■
a demand-side approach
Issues in estimating the economic cost of drug abuse in  ■
consuming nations
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EXASS Net 
On the initiative of the Finnish Presidency of the EU in 2006, 
a European network of multi-agency partnerships tackling 
drug problems at front-line level was established in 2007. 
Called EXASS Net, the network is managed by the Pompidou 
Group of the Council of Europe.1 
The fourth EXASS Network meting was held in Moscow in 
October 2008. The two-day programme included visits to 
the clinic of the National Research Centre on Addictions, 
the Moscow Scientifi c Practical Centre of Narcology and 
the Moscow State Technical University, and a number of 
presentations on different aspects of the Russian Federation’s 
response to drug use and misuse. Representatives of the 
EXASS Net Steering Group made presentations on the 
activities of the Pompidou Group, the European Forum for 
Urban Safety and the Correlation network.
The fi fth EXASS Net meeting took place in Budapest, 
Hungary, and looked at the issue of youth drug cultures, 
party drugs and club scenes. Future meetings are scheduled 
for Amsterdam and Oslo. These meetings will consider 
subjects including the role of drug users in developing 
responses, cannabis consumption and the role of outreach in 
response to drug problems. 
(Johnny Connolly)
1. More information about the EXASS Network and online 
reports of its meetings and other activities can be found 
at www.exass.net
The drugs problem and drug policy, developments  ■
between 1998 and 2007
The unintended consequences of drug policies ■
Methodological challenges in the country studies ■
The study found no evidence that the global drug problem 
had reduced during the UNGASS period from 1998 to 2007. 
Some of its key fi ndings are considered below.
The geography of drug production
Production of cocaine is increasingly centred in Colombia, 
and of opiates in Afghanistan. More than 170 countries 
produce cannabis and cultivation is increasingly found to be 
indoors and in small plots. Amphetamine-type substances 
are mainly produced in the Netherlands (ecstasy), Russia 
(amphetamine) and Myanmar (methamphetamine). 
The geography of consumption
Cannabis use has declined on a global level as prevalence 
rates have fallen from 2002 onwards. Frequent heroin 
use has declined in western industrialised states,3 but has 
increased in Russia and Central Asia. Cocaine prevalence 
rates have declined in the US while increasing in Europe. The 
European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) estimates that the number of drug-related deaths 
in Europe doubled between 1990 and 2000, but fell by 15% 
between 2000 and 2005. 
The size and profi tability of the global market
The study concludes that the United Nations Offi ce on 
Drugs and Crime (UNODC) estimate of the size of the global 
market (€280 billion) is infl ated. Though illicit drug markets 
generate more than €100 billion in sales, the vast majority 
of those involved make relatively modest incomes. Retail 
prices for heroin and cocaine have fallen in the US over the 
last 20 years and in Europe over the last fi ve years, despite a 
big increase in incarceration of heroin and cocaine sellers.
Drug policy
Countries take different approaches to controlling the use 
of illegal drugs: the US and Russia employ largely punitive 
policies, while the Netherlands and Switzerland regard the 
enforcement of criminal law as a last resort. Harm reduction 
has gained acceptance in a growing number of countries, 
including China and Iran. Iran has had in the past some of 
the harshest policies on drug use, but now sanctions the 
provision of methadone to over 100,000 opiate users. 
The report indicates that supply control policies tend 
to redistribute rather than suppress drug production, 
traffi cking and market activity, and have other unintended 
consequences, such as an increase in violent killings and the 
disruption of parent–child relationships due to incarceration 
policies. Ultimately, there is little evidence that national level 
supply control policies have had much success. Although 
global seizures, as a share of estimated global production, 
have risen substantially for both cocaine (from 23% in 
1998 to 42% in 2007) and heroin (from 13% in 1996 to 
23% in 2006), the lowering of price at consumption level 
throughout most regions would indicate that there remains 
a plentiful supply of illegal drugs from farm gate or factory 
to the street-level drug seller.
The fi rst comprehensive study of the Irish illicit drug market 
is currently being carried out by the Health Research Board. 
Commissioned by the National Advisory Committee on 
Drugs, this study is due for publication in 2010.
(Johnny Connolly and Anne Marie Donovan)
1. Reuter P and Trautmann F (eds) (2009) A report on global 
illicit drug markets 1998–2007. Report by the Trimbos 
Institute and RAND for the European Commission 
Directorate-General for Freedom, Justice and Security. 
Brussels: European Commission.
2. The country reports feature Australia, Brazil, Canada, 
China, Colombia, Czech Republic, Hungary, India, 
Mexico, the Netherlands, Portugal, Russian Federation, 
South Africa, Sweden, Switzerland, Turkey, the UK and 
the US.
3. The 2008 EMCDDA report states that new recruitment 
to heroin use is still occurring at a rate that will ensure 
that the problem will not decline signifi cantly in the 
foreseeable future.
Global illicit drug market (continued)
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In brief 
In January 2009 the European Society for Social Drug 
Research (ESSD) launched its website. Founded in 1990 
as an association of European social scientists working on 
drug issues, the ESSD’s principal aim is to promote social 
science approaches to drug research, with special reference 
to the situation in Europe. Its 2009 conference will be held in 
Belfast in September. www.essd-research.eu 
Between January and March 2009 the Employee Assistance 
Programmes Institute (EAPI) hosted three seminars in 
Waterford, Galway and Dublin, on complying with Section 
13 of the Safety, Health and Welfare at Work Act 2005, 
relating to drugs and alcohol at work. The EAPI reports that 
the Health and Safety Authority (HSA) has indicated that 
regulations on employee drug testing will not be introduced. 
Instead, the HSA will issue guidance after a period of 
consultation with interested parties. www.eapinstitute.com 
On 2 February 2009 INTERPOL and the World Anti-Doping 
Agency (WADA) signed a memorandum of understanding 
regarding co-operation in tackling the use of performance-
enhancing drugs in sport. The INTERPOL Secretary-General 
commented, ‘While doping is often viewed as a crime 
committed by an individual, the reality is that when an 
athlete takes illegal performance-enhancing drugs, this is just 
one piece in a larger network of criminality.’ 
www.interpol.com/www.wada-ama.org 
On 5 March 2009 the Housing (Miscellaneous Provisions) 
Bill 2008 was introduced into Dáil Éireann for its second 
reading. Section 35 of the Bill requires each local housing 
authority to adopt a strategy for the prevention and 
reduction of anti-social behaviour in its housing stock. The 
Bill also amends the defi nition of anti-social behaviour in 
the Housing (Miscellaneous Provisions) Act 1997, extending 
it to include damage to property, graffi ti and signifi cant 
impairment of the use or enjoyment of a person’s home. 
www.oireachtas.ie 
On 9 March 2009 the fi fth Joint report on social protection 
and social inclusion was jointly adopted by the Employment, 
Social Policy, Health and Consumer Affairs (EPSCO) Council 
and the European Commission. Regarding the impact of the 
economic recession on member states of the EU, the report 
stated, ‘The most badly hit victims of the crisis will be those 
households where breadwinners are at a disadvantage in 
the labour market and in society. Hence the need for social 
safety nets which are tight enough to prevent people from 
falling through and effective enough to launch them back 
into active social and labour market participation.’ 
http://ec.europa.eu/employment_social/spsi/index_en.htm 
On 10 March 2009 the National Economic and Social 
Council (NESC) stated that, as well as banking, fi scal, 
economic and reputational crises, Ireland faces ‘a social 
crisis of unemployment, income loss and indebtedness’. 
The Council argued that it was critical to protect those 
experiencing loss of employment, income, savings and 
pensions through holding a Jobs and Skills Summit. At this 
summit, the labour market authorities, and all bodies with 
a capacity to deliver high-quality, market-relevant training 
and education programmes, would identify and implement 
a set of measures that (1) re-order and re-fashion existing 
education, training and social welfare budgets to more 
effectively help workers losing their jobs and those seeking 
jobs for the fi rst time during the recession, and (2) create 
'21st-century' equivalents to the special labour market 
programmes introduced in the late 1980s and early 1990s. 
www.nesc.ie 
On 12 March 2009 Dublin City Business Improvement 
District (DBID) announced details of a new long-term 
partnership with the Ana Liffey Drug Project (ALDP). It 
will work with the ALDP in developing long-lasting solutions 
to reduce the problems for those directly affected by 
problematic substance misuse and homelessness and for the 
broader community in the city centre. www.aldp.ie 
In March 2009 the National Economic and Social Forum 
(NESF) published a report on the 5th Social Inclusion 
Forum (SIF), held in Dublin on 26 November 2008. The SIF 
was established by Government to provide an opportunity 
for a wide range of voluntary groups and individuals at 
local level to present their views and experiences, ideas 
and proposals, on key policies and implementation issues 
relating to the National Anti-Poverty Strategy (NAPS). With 
regard to facilitating employment participation by those 
vulnerable to exclusion from the labour market, the Forum 
suggested: (1) address discrimination among employers 
and service providers towards disadvantaged groups; (2) 
ensure appropriate progression pathways are available; 
(3) focus measures and services on those who are most 
distant from the labour market; and (4) co-ordinate policies, 
organisations and incentives at the local and national level. 
www.nesf.ie 
On 9 April 2009 headshops were the subject of a 
Parliamentary Question. Minister for Health and Children 
Mary Harney TD responded that John Curran, Minister 
of State with responsibility for co-ordinating the National 
Drugs Strategy, had identifi ed headshops ‘as an area of 
concern, and is currently considering the options available 
to more effectively control the activities of headshops’. www.
oireachtas.ie 
On 17 April 2009 the Criminal Justice (Surveillance) Bill 
2009 was introduced in Dáil Éireann. One purpose of the Bill 
is to buttress the work of the Garda Síochána, the Defence 
Forces and the Revenue Commissioners in the prevention 
and detection of serious crime. The Bill ensures that any legal 
obstacles to the admissibility in criminal trials of material 
obtained by means of secret surveillance are removed in 
cases involving arrestable offences. www.oireachtas.ie 
Between 20 and 23 April 2009 the International Harm 
Reduction Association (IHRA) held its annual conference 
in Bangkok. The conference theme was ‘harm reduction and 
human rights’. www.ihra.net 
On 21 April 2009 the Ana Liffey Drug Project's ‘Duck Dive 
& Survive’ initiative won a prize in the Crystal Clear MSD 
Health Literacy Awards 2009. The initiative consists of two 
clearly-written leafl ets promoting ALDP’s peer support group 
and the outreach service. ALDP plans to use the €3,000 
prize fund to establish a free text messaging service that 
will provide essential real-time information to service users. 
www.aldp.ie 
On 30 April 2009 the Central Statistics Offi ce (CSO) 
released Recorded crime for quarter 1 (Q1) 2009. The 
bulletin reported that the number of controlled drug 
offences increased by 5%, from 5,240 to 5,503, between Q1 
of 2008 and Q1 of 2009. Possession of drugs for personal 
use offences rose from 3,893 to 4,286 over this period, an 
increase of 10.1%. www.cso.ie 
(Compiled by Brigid Pike) 
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Recent publications
Journal articles
The following abstracts are cited from recently 
published articles relating to the drug situation 
in Ireland.
A profi le of adolescent cocaine use in 
Northern Ireland
McCrystal P and Percy A 
International Journal of Drug Policy 2009; 20(4): 
357–364
The image of cocaine as a ‘party’ drug used by 
more affl uent members of society has begun to 
change as the levels of use of the drug rise among 
school-aged young people. This study aimed to 
provide data on the prevalence estimates and 
associated behaviours of cocaine use among school 
attenders, a group that traditionally has received 
relatively little attention in the cocaine literature. 
Cocaine use patterns among young people 
aged 13–16 years who were participating in the 
Belfast Youth Development Study, a longitudinal 
study of adolescent drug use was explored. Data 
was collected through an annual data sweep in 
participating schools. This paper includes data 
collected in years 3, 4 and 5 of the study.
The results show higher levels of cocaine use 
among this age group than reported in much of 
the existing harm reduction literature. Lifetime 
use was 3.8% at age 13–14 years, rising to 
7.5% at 15–16 years. The profi le indicated that 
adolescent cocaine users were more likely to be 
female, live in disrupted families and experience 
social deprivation, which is similar to existing 
adolescent drug- user profi les. There was also some 
evidence of experimental cocaine use among the 
sample. These fi ndings provide further evidence 
for the development of age-appropriate, school-
focused harm reduction initiatives and continued 
monitoring of contemporary trends of use of 
cocaine among school-aged young people.
Cannabis reclassifi cation: What is the message to 
the next generation of cannabis users? 
McCrystal P and Winning K 
Child Care in Practice 2009; 15(1): 57–73
At the beginning of 2004 the UK government 
downgraded the legal status of cannabis from a 
Class B to a Class C drug. Following a review of 
this decision two years later, cannabis remained 
a Class C substance –which for some contrasted 
with the potential harmful social and health effects 
associated with its use, particularly for young 
people. These included its links with respiratory 
damage, problems during pregnancy and its 
potential to exacerbate mental health problems. 
When Gordon Brown became Prime Minister in 
June 2007 his government decided to revisit this 
issue and requested a re-examination of its legal 
status. Despite the advice of its own scientifi c 
advisory body, the Advisory Council on the Misuse 
of Drugs, the UK government reclassifi ed cannabis 
back to a Class B drug in May 2008. 
This paper examines the existing scientifi c evidence 
on the potential impact of cannabis use on young 
people within the context of the UK government's 
reclassifi cation initiative over the past four years. 
This evidence remains inconclusive whilst the 
perception of young people to the effects of 
cannabis use during, and now after, the period 
of the reclassifi cation debate is not yet known. 
This now makes it particularly challenging to 
communicate a clear message in the most effective 
manner with young people about the possible 
risks of cannabis use, and would appear to make 
it diffi cult to provide a clear and unambiguous 
statement on what message this initiative has sent 
to the next generation of cannabis users, as they 
see the government rethink its position on several 
occasions before eventually changing 
its mind. 
Alcohol misuse in the general hospital: some 
hard facts 
Bradshaw P, Denny M and Cassidy E 
Irish Journal of Medical Science 2008; 177(4): 
339–342
Alcohol misuse is associated with considerable 
physical, psychological and social morbidity. The 
annual direct healthcare cost of alcohol-related 
problems in Ireland has been estimated to be 
433 million Euro. There is also evidence that 
this population alcohol problem is refl ected in 
attendances at and admissions to general hospitals. 
This study aimed to examine (1) the prevalence 
of alcohol use disorders in adult general hospital 
inpatients; (2) the accuracy of documentation 
in relation to alcohol use. A total of 210 random 
patients were interviewed out of 1,448 consecutive 
new admissions to Cork University Hospital over 
seven days. Case notes were reviewed for 206 
(98%). Alcohol consumption was assessed using 
the Fast Alcohol Screening Test (FAST) and weekly 
drinking diary. FAST-positive (and a random sample 
of FAST-negative) patients then had a standardised 
interview. A total of 82% admitted for drinking 
alcohol. Among them, 22% were drinking in excess 
of guidelines, 9% had DSM-IV Alcohol Abuse and 
7% dependence. The sensitivity and specifi city 
of the FAST for detecting those drinking above 
guidelines were 89 and 94%, and for detecting a 
DSM-IV diagnosis was 100 and 73%. The majority 
of case notes contained inadequate information 
about alcohol intake. The authors conclude that 
alcohol use disorders are common and often 
undetected in the general hospital setting. 
Chronic illness and multimorbidity among 
problem drug users: a comparative cross 
sectional pilot study in primary care 
Cullen W, O’Brien S, O’Carroll A, O’Kelly FD 
and Bury G 
BMC Family Practice 2009; 10(1): 25
Although multimorbidity has important implications 
for patient care in general practice, limited research 
has examined chronic illness and health service 
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utilisation among problem drug users. This study 
aimed to determine chronic illness prevalence and 
health service utilisation among problem drug users 
attending primary care for methadone treatment, 
to compare these rates with matched 'controls' and 
to develop and pilot test a valid study instrument. 
A cross-sectional study of patients attending three 
large urban general practices in Dublin, Ireland, 
for methadone treatment was conducted, and 
this sample was compared with a control group 
matched by practice, age, gender and General 
Medical Services (GMS) status. 
Data were collected on 114 patients. Fifty-seven 
patients were on methadone treatment, of whom 
52(91%) had at least one chronic illness (other then 
substance use) and 39(68%) were prescribed at 
least one regular medication. Frequent utilisation 
of primary care services and secondary care 
services in the previous six months was observed 
among patients on methadone treatment and 
controls, although the former had signifi cantly 
higher chronic illness prevalence and primary care 
contact rates. The study instrument facilitated 
data collection that was feasible and with minimal 
inter-observer variation. The authors conclude that 
multimorbidity is common among problem drug 
users attending general practice for methadone 
treatment. Primary care may therefore have an 
important role in primary and secondary prevention 
of chronic illnesses among this population. This 
study offers a feasible study instrument for further 
work on this issue. 
The development of a qualitative real-time RT-
PCR assay for the detection of hepatitis C virus 
Clancy A, Crowley B, Niesters H and Herra C 
European Journal of Clinical Microbiology & Infectious 
Diseases 2008; 27(12): 1177–1182
Real-time polymerase chain reaction (PCR) 
represents a favourable option for the detection 
of hepatitis C virus (HCV). A real-time reverse 
transcriptase PCR (RT-PCR) assay was developed 
as a qualitative diagnostic screening method for 
the detection of HCV using the ABI PRISM® 7500 
Sequence Detection System. The primers and 
probe were designed to target the 5 -untranslated 
region of the hepatitis C viral genome. A second 
heterologous probe assay was developed for the 
detection of the haemagglutinin gene of phocine 
distemper virus (PDV) and was used as an internal 
control. A semi-automated HCV extraction method 
was also implemented using the ABI PRISM™ 
6100 Nucleic Acid PrepStation. The HCV assay 
was optimised as a qualitative singleplex RT-PCR 
assay with parallel testing of the target and internal 
control. 
The assay results (n = 200) were compared to the 
COBAS AMPLICOR™ HCV Test v2.0 assay. The 
assay demonstrated a high rate of sensitivity (99%), 
specifi city (100%) and an acceptable limit of 
detection (LOD) of 100 IU/ml. The development of 
a qualitative multiplex assay for the simultaneous 
detection of HCV and internal control indicates the 
same high rates of sensitivity and specifi city. This 
sensitive real-time assay may prove to be a valuable 
method for the detection of HCV. 
(Compiled by Louise Farragher)
Recent publications (continued)
Upcoming events
(Compiled by Louise Farragher – lfarragher@hrb.ie)
October
7–9 October 2009
Models, implications and meanings of alcohol and 
drug treatment systems. A thematic meeting of the 
Kettil Bruun Society for Social and Epidemiological 
Research on Alcohol
Venue: Stockholm, Sweden 
Organised by/Contact: NAD, Kettil Bruun Society 
Tel: +44 (0) 20 7554 8533 
Email: nads@nad.fi  
www.nad.fi /index.php?lang=en
Information: The question of how best to allocate 
resources for treatment of alcohol and drug 
problems is increasingly important, not only in 
developing countries but also in affl uent societies. 
The aim of this meeting is to develop and discuss 
new perspectives on alcohol and drug treatment 
systems, to encourage comparative research 
and to stimulate theoretical and methodological 
discussion among researchers from fi elds with 
similar perspectives, such as mental health and care 
of the disabled. The meeting will strive to attract an 
international group of researchers, with support for 
researchers from low and middle income countries. 
11–16 October 2009
Shaping the Future - A Multisectorial Challenge. 
52nd International ICAA Conference on 
Dependencies 
Venue: Estoril, Portugal 
Organised by/Contact: International Council on 
Alcohol and Addictions 
Tel: +44 (0)141 548 4507 
Email: icaa2009@icaa.ch 
www.icaa.ch/ICAA_Estoril_2009.html 
Information: The conference will focus on 
identifying future trends in addiction prevention, 
treatment and policy and how practitioners 
should respond to these. The programme will 
include plenary sessions with keynote speakers of 
international renown addressing the conference's 
major themes. 
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National Conference on Injecting Drug Use 
(NCIDU)
Venue: Radisson Hotel, Glasgow 
Organised by/Contact: Exchange Supplies 
Email: www.exchangesupplies.org
Information: A packed and varied programme 
with over 30 parallel sessions, meetings, poster 
presentations and fi lms to inform practice, 
disseminate research, explore policy and 
develop skills. If you would like to present a 
paper or workshop session on a subject relevant 
to the conference themes, please see full 
abstract submission details on our website, or 
call +44 (0)1305 262244.
November
11–14 November 2009
Reform 2009: The International Drug Policy 
Reform Conference
Venue: Albuquerque Convention Center, New 
Mexico, USA 
Organised by/Contact: Stephanie Jones 
Email: sjones@drugpolicy.org 
www.drugpolicyevent.com 
Information: This biennial conference brings 
together representatives from every corner of 
the drug policy reform movement – activists 
and students, drug users and those in recovery, 
harm reduction and treatment professionals, law 
enforcers and the formerly incarcerated – for 
three days of learning, debate and strategising. 
Topics covered will include: the latest 
developments in alternatives to incarceration, 
harm reduction innovations, law enforcement 
and treatment, the history and future of 
psychoactive drugs, and drug policy reform 
locally, nationally and globally. 
16–18 November 2009 
11th International Hepatitis C Conference 
Venue: Lowry Hotel, Manchester, UK 
Organised by/Contact: Mainliners, 1 London 
Bridge, London SE1 4BG 
Email: international09@mainliners.org.uk 
www.hepc09.org.uk 
Information: This conference will be a 
three-day event with a full programme of 
international speakers and oral abstract 
presentations. It is being organised by the 
Hepatitis C Resource Centre, a project of 
Mainliners, in partnership with the Greater 
Manchester Hepatitis C Strategy. 
The Alcohol and Drug Research Unit (ADRU) of the Health Research Board is a multi-
disciplinary team of researchers and information specialists who provide objective, reliable 
and comparable information on the drug and alcohol situation, its consequences and 
responses in Ireland. 
The ADRU maintains two national drug-related surveillance systems and is the national 
focal point for the European Monitoring Centre for Drugs and Drug Addiction. The unit also 
manages the National Documentation Centre on Drug Use. 
The ADRU disseminates research fi ndings, information and news through its quarterly 
newsletter, Drugnet Ireland, and the HRB series publications. Through its activities, the ADRU 
aims to inform policy and practice in relation to drug and alcohol use.
Drugnet Ireland is 
published by:
Alcohol and Drug 
Research Unit
Health Research Board
Knockmaun House
42–47 Lower Mount Street
Dublin 2
Tel: + 353 1 2345 127
Email: adru@hrb.ie
Managing editor: 
Brian Galvin
Editor: Joan Moore
Upcoming events (continued)
Improving people’s health through research and information
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